Inguinal hernia repair in patients with artificial urinary sphincter after radical prostatectomy

PURPOSE

Stress urinary incontinence (UI) often develops after radical prostatectomy for prostate cancer, and in those patients with moderate-to-severe stress UI an artificial urinary sphincter (AUS) is implanted. Inguinal hernias (IHs) often occur after radical prostatectomy. As the prevalence of AUS implantation increases, it is possible to encounter patients with IHs undergoing AUS implantation (IHA). This study investigated our treatment and discussed an appropriate approach for IHAs.

METHODS

We retrospectively investigated patients who underwent IH repair with AUS implantation at our hospital from January 2018 to March 2023. We classified IHAs into Types A-D based on the positions of the IHs and AUS devices (the positions of the control pump, pressure-regulating balloon, and connecting tube). The hernia and control pump were ipsilateral in Types A and B, whereas the hernia and pressure-regulating balloon were ipsilateral in Types A and C.

RESULTS

This study included 12 IHs of 11 patients. The median patient age was 77 years. We conducted open repair in nine patients with all types and laparoscopic repair in two patients with Type B. The median operation times for unilateral and bilateral repairs were 96 and 182 min, respectively. There were no complications with AUS or hernia surgeries.

CONCLUSION

IHA has its own characteristics, and multidisciplinary knowledge thereof will help surgeons safely perform IH surgery.

Stepwise algorithm using computed tomography and magnetic resonance imaging for differential diagnosis of fat-poor angiomyolipoma in small renal masses: A prospective validation study

OBJECTIVES

To validate the diagnostic accuracy of a stepwise algorithm to differentiate fat-poor angiomyolipoma (fp-AML) from renal cancer in small renal masses (SRMs).

METHODS

We prospectively enrolled 223 patients with solid renal masses <4 cm and no visible fat on unenhanced computed tomography (CT). Patients were assessed using an algorithm that utilized the dynamic CT and MRI findings in a stepwise manner. The diagnostic accuracy of the algorithm was evaluated in patients whose histology was confirmed through surgery or biopsy. The clinical course of the patients was further analyzed.

RESULTS

The algorithm classified 151 (68%)/42 (19%)/30 (13%) patients into low/intermediate/high AML probability groups, respectively. Pathological diagnosis was made for 183 patients, including 10 (5.5%) with fp-AML. Of these, 135 (74%)/36 (20%)/12 (6.6%) were classified into the low/intermediate/high AML probability groups, and each group included 1 (0.7%)/3 (8.3%)/6 (50%) fp-AMLs, respectively, leading to the area under the curve for predicting AML of 0.889. Surgery was commonly opted in the low and intermediate AML probability groups (84% and 64%, respectively) for initial management, while surveillance was selected in the high AML probability group (63%). During the 56-month follow-up, 36 (82%) of 44 patients initially surveyed, including 13 of 18 (72%), 6 of 7 (86%), and 17 of 19 (89%) in the low/intermediate/high AML probability groups, respectively, continued surveillance without any progression.

CONCLUSIONS

This study confirmed the high diagnostic accuracy for differentiating fp-AMLs. These findings may help in the management of patients with SRMs.

Neoadjuvant Chemoradiotherapy Followed by Radical Cystectomy for Muscle-Invasive Bladder Cancer: Analysis of Efficacy and Safety in 119 Patients

INTRODUCTION

Cisplatin-based systemic chemotherapy is recommended as neoadjuvant treatment for muscle-invasive bladder cancer (MIBC) before radical cystectomy (RC). However, clinical challenges include the possibility of primary chemoresistance and limited feasibility in patients with renal impairment. This study investigated the efficacy and safety profiles of neoadjuvant chemoradiotherapy (NCRT) followed by RC.

MATERIALS AND METHODS

We retrospectively analyzed 119 patients with nonmetastatic MIBC, who were pathologically diagnosed with urothelial carcinoma and underwent NCRT before RC. The pathological response to NCRT was evaluated using RC specimens. Recurrence-free survival (RFS) and cancer-specific survival (CSS) were compared according to pathological responses to NCRT.

RESULTS

Of the 119 patients, 111 (93%) underwent RC; ypT0 and downstaging to ≤ypT1 were observed in 42 (38%) and 76 (68%) patients, respectively. In the multivariable analysis, smaller tumor size was independently associated with ypT0. During a median follow-up of 5.2 years, 28 (25%) patients developed recurrence and 22 (20%) died of bladder cancer after RC. The 5-year RFS and CSS rates were 75% and 80%, respectively. The 5-year RFS rates in patients with ypT0, ypTa/is/1, and ≥ypT2 were 87%, 87%, and 46%, respectively. Similarly, patients with ypT0 and ypTa/is/1 had more favorable CSS (90% and 87% at 5 years, respectively) than those with ≥ypT2 (60%, P = .001). None of the patients experienced ≥grade 4 adverse events related to NCRT or ≥grade 4 complications of RC.

CONCLUSIONS

This study demonstrated sufficient efficacy and safety profile of NCRT followed by RC. Chemoradiotherapy may be a helpful alternative for neoadjuvant treatment before RC.

Unraveling the BMI paradox in different renal cortical tumors: insights from the INMARC registry

OBJECTIVE

To investigate impact of body mass index (BMI) on survival across different histologies and stages of renal cell carcinoma (RCC).

METHODS

We conducted a retrospective multicenter analysis of clear cell (ccRCC) and non-ccRCC. Obesity was defined according to the WHO criteria (non-Asian BMI >30 Kg/m2, Asian BMI >27.5 Kg/m2). Multivariable analysis (MVA) via Cox regression model was conducted for all-cause (ACM), cancer-specific mortality (CSM) and recurrence.

RESULTS

A total of 3,880 patients with a median follow-up of 31 (IQR 9-64) months were analyzed. Overall, 1,373 (35.3%) were obese; 2,895 (74.6%) were ccRCC and 985 (25.3%) were non-ccRCC (chRCC 246 [24.9%], pRCC 469 [47.6%] and vhRCC 270 [27.4%]). MVA in ccRCC revealed obesity associated with decreased risk of ACM, CSM and recurrence (hazard ratio [HR] 0.80, P = 0.044; HR 0.71, P = 0.039; HR 0.73, P = 0.012, respectively), while in non-ccRCC was not associated with decreased risk of ACM, CSM, and recurrence (P = 0.84, P = 0.53, P = 0.84, respectively). Subset analysis in stage IV ccRCC demonstrated obesity as associated with a decreased risk of ACM, CSM, and recurrence (HR 0.68, P = 0.04; HR 0.59, P = 0.01; HR 0.59, P = 0.01, respectively), while in stage I-III ccRCC was not (P = 0.21; P = 0.30; P = 0.19, respectively).

CONCLUSION

Our findings refute a broad "obesity paradox" for RCC. Obesity was not associated with improved survival in non-ccRCC and in nonmetastatic ccRCC, while metastatic ccRCC patients with obesity had improved survival outcomes.

Amplitude Analysis of the B^{0}→K^{*0}μ^{+}μ^{-} Decay

An amplitude analysis of the B^{0}→K^{*0}μ^{+}μ^{-} decay is presented using a dataset corresponding to an integrated luminosity of 4.7  fb^{-1} of pp collision data collected with the LHCb experiment. For the first time, the coefficients associated to short-distance physics effects, sensitive to processes beyond the standard model, are extracted directly from the data through a q^{2}-unbinned amplitude analysis, where q^{2} is the μ^{+}μ^{-} invariant mass squared. Long-distance contributions, which originate from nonfactorizable QCD processes, are systematically investigated, and the most accurate assessment to date of their impact on the physical observables is obtained. The pattern of measured corrections to the short-distance couplings is found to be consistent with previous analyses of b- to s-quark transitions, with the largest discrepancy from the standard model predictions found to be at the level of 1.8 standard deviations. The global significance of the observed differences in the decay is 1.4 standard deviations.

Utility of positive core number on MRI-ultrasound fusion targeted biopsy in combination with PI-RADS scores for predicting unexpected extracapsular extension of clinically localized prostate cancer

OBJECTIVES

To evaluate the utility of magnetic resonance imaging (MRI) and MRI-ultrasound fusion targeted biopsy (TB) for predicting unexpected extracapsular extension (ECE) in clinically localized prostate cancer (CLPC).

METHODS

This study enrolled 89 prostate cancer patients with one or more lesions showing a Prostate Imaging-Reporting and Data System (PI-RADS) score ≥3 but without morphological abnormality in the prostatic capsule on pre-biopsy MRI. All patients underwent TB and systematic biopsy followed by radical prostatectomy (RP). Each lesion was examined by 3-core TB, taking cores from each third of the lesion. The preoperative variables predictive of ECE were explored by referring to RP specimens in the lesion-based analysis.

RESULTS

Overall, 186 lesions, including 81 (43.5%), 73 (39.2%), and 32 (17.2%) with PI-RADS 3, 4, and 5, respectively, were analyzed. One hundred and twenty-two lesions (65.6%) were diagnosed as cancer on TB, and ECE was identified in 33 (17.7%) on the RP specimens. The positive TB core number was ≤2 in 129 lesions (69.4%) and three in 57 lesions (30.6%). On the multivariate analysis, PI-RADS ≥4 (p = 0.049, odds ratio [OR] = 2.39) and three positive cores on TB (p = 0.005, OR = 3.07) were independent predictors of ECE. Lesions with PI-RADS ≥4 and a positive TB core number of 3 had a significantly higher rate of ECE than those with PI-RADS 3 and a positive TB core number ≤2 (37.5% vs. 7.8%, p < 0.001).

CONCLUSIONS

Positive TB core number in combination with PI-RADS scores is helpful to predict unexpected ECE in CLPC.

Phase I/IIa trial of 18F-prostate specific membrane antigen (PSMA) 1007 PET/CT in healthy volunteers and prostate cancer patients

OBJECTIVE

18F-PSMA 1007 is a promising PET tracer for prostate cancer. We aimed to examine the safety, biodistribution, radiation dosimetry, and clinical effectiveness in Japanese healthy volunteers and patients with prostate cancer.

METHODS

Part A evaluated the pharmacokinetics and exposure doses in three healthy volunteers. Part B evaluated the diagnostic accuracy in patients with untreated preoperative prostate cancer (Cohort 1, n = 7) and patients with biochemical recurrence (Cohort 2, n = 3). All subjects received a single dose of 3.7 MBq/kg 18F-PSMA 1007. Results: 18F-PSMA 1007 was found to be safe and well tolerated in all subjects. No serous AEs or drug-related AEs were identified during the present study. The average blood radioactivity concentration reached a maximum of 47.87 ± 1.05 (percentage of injected dose [%ID]/ml) at 5 min and then decreased to 1.60 ± 0.78 in 6 h. The systemic radioactivity reached a maximum of 211.05 ± 6.77 (%ID$\times$103) at 5 min and decreased to 7.18 ± 3.91 in 6 h. The sensitivity and positive predictive value were 100% and 100% based on both pathologic and imaging confirmation as gold standard. In Cohort 1, 15 primary foci (11.9%) were >5 mm in the largest diameter and identified in 39 of 126 segments (30.1%). The sensitivity, specificity, positive predictive value, negative predictive value, and accuracy for 60 min uptake time acquisition were 80.0, 96.5, 91.4, 91.2 and 91.3%, respectively.

CONCLUSIONS

Our study revealed that 18F-PSMA 1007 was safe, well tolerated and showed high accuracy in the diagnosis of prostate cancer.

Fraction of χ_{c} Decays in Prompt J/ψ Production Measured in pPb Collisions at sqrt[s_{NN}]=8.16 TeV

The fraction of χ_{c1} and χ_{c2} decays in the prompt J/ψ yield, F_{χ_{c}→J/ψ}=σ_{χ_{c}→J/ψ}/σ_{J/ψ}, is measured by the LHCb detector in pPb collisions at sqrt[s_{NN}]=8.16  TeV. The study covers the forward (1.5 Collapse

Key Words Collapse

MESH Headings Collapse

Grants Collapse

Affiliation(s)

R Aaij Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands
A S W Abdelmotteleb Department of Physics, University of Warwick, Coventry, United Kingdom
C Abellan Beteta Physik-Institut, Universität Zürich, Zürich, Switzerland
F Abudinén Department of Physics, University of Warwick, Coventry, United Kingdom
T Ackernley Oliver Lodge Laboratory, University of Liverpool, Liverpool, United Kingdom
B Adeva Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
M Adinolfi H.H. Wills Physics Laboratory, University of Bristol, Bristol, United Kingdom
P Adlarson Department of Physics and Astronomy, Uppsala University, Uppsala, Sweden (associated with School of Physics and Astronomy, University of Glasgow, Glasgow, United Kingdom)
C Agapopoulou European Organization for Nuclear Research (CERN), Geneva, Switzerland
C A Aidala University of Michigan, Ann Arbor, Michigan, USA (associated with Syracuse University, Syracuse, New York, USA)
Z Ajaltouni Université Clermont Auvergne, CNRS/IN2P3, LPC, Clermont-Ferrand, France
S Akar University of Cincinnati, Cincinnati, Ohio, USA
K Akiba Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands
P Albicocco INFN Laboratori Nazionali di Frascati, Frascati, Italy
J Albrecht Fakultät Physik, Technische Universität Dortmund, Dortmund, Germany
F Alessio European Organization for Nuclear Research (CERN), Geneva, Switzerland
M Alexander School of Physics and Astronomy, University of Glasgow, Glasgow, United Kingdom
A Alfonso Albero ICCUB, Universitat de Barcelona, Barcelona, Spain
Z Aliouche Department of Physics and Astronomy, University of Manchester, Manchester, United Kingdom
P Alvarez Cartelle Cavendish Laboratory, University of Cambridge, Cambridge, United Kingdom
R Amalric LPNHE, Sorbonne Université, Paris Diderot Sorbonne Paris Cité, CNRS/IN2P3, Paris, France
S Amato Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil
J L Amey H.H. Wills Physics Laboratory, University of Bristol, Bristol, United Kingdom
Y Amhis Université Paris-Saclay, CNRS/IN2P3, IJCLab, Orsay, France European Organization for Nuclear Research (CERN), Geneva, Switzerland
L An School of Physics State Key Laboratory of Nuclear Physics and Technology, Peking University, Beijing, China
L Anderlini INFN Sezione di Firenze, Firenze, Italy
M Andersson Physik-Institut, Universität Zürich, Zürich, Switzerland
A Andreianov Affiliated with an institute covered by a cooperation agreement with CERN
P Andreola Physik-Institut, Universität Zürich, Zürich, Switzerland
M Andreotti INFN Sezione di Ferrara, Ferrara, Italy
D Andreou Syracuse University, Syracuse, New York, USA
A A Anelli INFN Sezione di Milano-Bicocca, Milano, Italy
D Ao University of Chinese Academy of Sciences, Beijing, China
F Archilli INFN Sezione di Roma Tor Vergata, Roma, Italy
M Argenton INFN Sezione di Ferrara, Ferrara, Italy
S Arguedas Cuendis Consejo Nacional de Rectores (CONARE), San Jose, Costa Rica
A Artamonov Affiliated with an institute covered by a cooperation agreement with CERN
M Artuso Syracuse University, Syracuse, New York, USA
E Aslanides Aix Marseille Univ, CNRS/IN2P3, CPPM, Marseille, France
M Atzeni Massachusetts Institute of Technology, Cambridge, Massachusetts, USA
B Audurier Laboratoire Leprince-Ringuet, CNRS/IN2P3, Ecole Polytechnique, Institut Polytechnique de Paris, Palaiseau, France
D Bacher Department of Physics, University of Oxford, Oxford, United Kingdom
I Bachiller Perea Université Savoie Mont Blanc, CNRS, IN2P3-LAPP, Annecy, France
S Bachmann Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
M Bachmayer Institute of Physics, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland
J J Back Department of Physics, University of Warwick, Coventry, United Kingdom
A Bailly-Reyre LPNHE, Sorbonne Université, Paris Diderot Sorbonne Paris Cité, CNRS/IN2P3, Paris, France
P Baladron Rodriguez Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
V Balagura Laboratoire Leprince-Ringuet, CNRS/IN2P3, Ecole Polytechnique, Institut Polytechnique de Paris, Palaiseau, France
W Baldini INFN Sezione di Ferrara, Ferrara, Italy
J Baptista de Souza Leite Centro Brasileiro de Pesquisas Físicas (CBPF), Rio de Janeiro, Brazil
M Barbetti INFN Sezione di Firenze, Firenze, Italy
I R Barbosa Pontifícia Universidade Católica do Rio de Janeiro (PUC-Rio), Rio de Janeiro, Brazil (associated with Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil)
R J Barlow Department of Physics and Astronomy, University of Manchester, Manchester, United Kingdom
S Barsuk Université Paris-Saclay, CNRS/IN2P3, IJCLab, Orsay, France
W Barter School of Physics and Astronomy, University of Edinburgh, Edinburgh, United Kingdom
M Bartolini Cavendish Laboratory, University of Cambridge, Cambridge, United Kingdom
F Baryshnikov Affiliated with an institute covered by a cooperation agreement with CERN
J M Basels I. Physikalisches Institut, RWTH Aachen University, Aachen, Germany
G Bassi INFN Sezione di Pisa, Pisa, Italy
B Batsukh Institute Of High Energy Physics (IHEP), Beijing, China
A Battig Fakultät Physik, Technische Universität Dortmund, Dortmund, Germany
A Bay Institute of Physics, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland
A Beck Department of Physics, University of Warwick, Coventry, United Kingdom
M Becker Fakultät Physik, Technische Universität Dortmund, Dortmund, Germany
F Bedeschi INFN Sezione di Pisa, Pisa, Italy
I B Bediaga Centro Brasileiro de Pesquisas Físicas (CBPF), Rio de Janeiro, Brazil
A Beiter Syracuse University, Syracuse, New York, USA
S Belin Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
V Bellee Physik-Institut, Universität Zürich, Zürich, Switzerland
K Belous Affiliated with an institute covered by a cooperation agreement with CERN
I Belov INFN Sezione di Genova, Genova, Italy
I Belyaev Affiliated with an institute covered by a cooperation agreement with CERN
G Benane Aix Marseille Univ, CNRS/IN2P3, CPPM, Marseille, France
G Bencivenni INFN Laboratori Nazionali di Frascati, Frascati, Italy
E Ben-Haim LPNHE, Sorbonne Université, Paris Diderot Sorbonne Paris Cité, CNRS/IN2P3, Paris, France
A Berezhnoy Affiliated with an institute covered by a cooperation agreement with CERN
R Bernet Physik-Institut, Universität Zürich, Zürich, Switzerland
S Bernet Andres DS4DS, La Salle, Universitat Ramon Llull, Barcelona, Spain
H C Bernstein Syracuse University, Syracuse, New York, USA
C Bertella Department of Physics and Astronomy, University of Manchester, Manchester, United Kingdom
A Bertolin Università degli Studi di Padova, Università e INFN, Padova, Padova, Italy
C Betancourt Physik-Institut, Universität Zürich, Zürich, Switzerland
F Betti School of Physics and Astronomy, University of Edinburgh, Edinburgh, United Kingdom
J Bex Cavendish Laboratory, University of Cambridge, Cambridge, United Kingdom
Ia Bezshyiko Physik-Institut, Universität Zürich, Zürich, Switzerland
J Bhom Henryk Niewodniczanski Institute of Nuclear Physics Polish Academy of Sciences, Kraków, Poland
M S Bieker Fakultät Physik, Technische Universität Dortmund, Dortmund, Germany
N V Biesuz INFN Sezione di Ferrara, Ferrara, Italy
P Billoir LPNHE, Sorbonne Université, Paris Diderot Sorbonne Paris Cité, CNRS/IN2P3, Paris, France
A Biolchini Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands
M Birch Imperial College London, London, United Kingdom
F C R Bishop Université Savoie Mont Blanc, CNRS, IN2P3-LAPP, Annecy, France
A Bitadze Department of Physics and Astronomy, University of Manchester, Manchester, United Kingdom
A Bizzeti School of Physics and Astronomy, Monash University, Melbourne, Australia Centro Brasileiro de Pesquisas Físicas (CBPF), Rio de Janeiro, Brazil Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil Center for High Energy Physics, Tsinghua University, Beijing, China Institute Of High Energy Physics (IHEP), Beijing, China School of Physics State Key Laboratory of Nuclear Physics and Technology, Peking University, Beijing, China University of Chinese Academy of Sciences, Beijing, China Institute of Particle Physics, Central China Normal University, Wuhan, Hubei, China Consejo Nacional de Rectores (CONARE), San Jose, Costa Rica Université Savoie Mont Blanc, CNRS, IN2P3-LAPP, Annecy, France Université Clermont Auvergne, CNRS/IN2P3, LPC, Clermont-Ferrand, France Aix Marseille Univ, CNRS/IN2P3, CPPM, Marseille, France Université Paris-Saclay, CNRS/IN2P3, IJCLab, Orsay, France Laboratoire Leprince-Ringuet, CNRS/IN2P3, Ecole Polytechnique, Institut Polytechnique de Paris, Palaiseau, France LPNHE, Sorbonne Université, Paris Diderot Sorbonne Paris Cité, CNRS/IN2P3, Paris, France I. Physikalisches Institut, RWTH Aachen University, Aachen, Germany Fakultät Physik, Technische Universität Dortmund, Dortmund, Germany Max-Planck-Institut für Kernphysik (MPIK), Heidelberg, Germany Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany School of Physics, University College Dublin, Dublin, Ireland INFN Sezione di Bari, Bari, Italy INFN Sezione di Bologna, Bologna, Italy INFN Sezione di Ferrara, Ferrara, Italy INFN Sezione di Firenze, Firenze, Italy INFN Laboratori Nazionali di Frascati, Frascati, Italy INFN Sezione di Genova, Genova, Italy INFN Sezione di Milano, Milano, Italy INFN Sezione di Milano-Bicocca, Milano, Italy INFN Sezione di Cagliari, Monserrato, Italy Università degli Studi di Padova, Università e INFN, Padova, Padova, Italy INFN Sezione di Perugia, Perugia, Italy INFN Sezione di Pisa, Pisa, Italy INFN Sezione di Roma La Sapienza, Roma, Italy INFN Sezione di Roma Tor Vergata, Roma, Italy Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands Nikhef National Institute for Subatomic Physics and VU University Amsterdam, Amsterdam, Netherlands AGH - University of Science and Technology, Faculty of Physics and Applied Computer Science, Kraków, Poland Henryk Niewodniczanski Institute of Nuclear Physics Polish Academy of Sciences, Kraków, Poland National Center for Nuclear Research (NCBJ), Warsaw, Poland Horia Hulubei National Institute of Physics and Nuclear Engineering, Bucharest-Magurele, Romania Affiliated with an institute covered by a cooperation agreement with CERN DS4DS, La Salle, Universitat Ramon Llull, Barcelona, Spain ICCUB, Universitat de Barcelona, Barcelona, Spain Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain Instituto de Fisica Corpuscular, Centro Mixto Universidad de Valencia - CSIC, Valencia, Spain European Organization for Nuclear Research (CERN), Geneva, Switzerland Institute of Physics, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland Physik-Institut, Universität Zürich, Zürich, Switzerland NSC Kharkiv Institute of Physics and Technology (NSC KIPT), Kharkiv, Ukraine Institute for Nuclear Research of the National Academy of Sciences (KINR), Kyiv, Ukraine University of Birmingham, Birmingham, United Kingdom H.H. Wills Physics Laboratory, University of Bristol, Bristol, United Kingdom Cavendish Laboratory, University of Cambridge, Cambridge, United Kingdom Department of Physics, University of Warwick, Coventry, United Kingdom STFC Rutherford Appleton Laboratory, Didcot, United Kingdom School of Physics and Astronomy, University of Edinburgh, Edinburgh, United Kingdom School of Physics and Astronomy, University of Glasgow, Glasgow, United Kingdom Oliver Lodge Laboratory, University of Liverpool, Liverpool, United Kingdom Imperial College London, London, United Kingdom Department of Physics and Astronomy, University of Manchester, Manchester, United Kingdom Department of Physics, University of Oxford, Oxford, United Kingdom Massachusetts Institute of Technology, Cambridge, Massachusetts, USA University of Cincinnati, Cincinnati, Ohio, USA University of Maryland, College Park, Maryland, USA Los Alamos National Laboratory (LANL), Los Alamos, New Mexico, USA Syracuse University, Syracuse, New York, USA Pontifícia Universidade Católica do Rio de Janeiro (PUC-Rio), Rio de Janeiro, Brazil (associated with Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil) School of Physics and Electronics, Hunan University, Changsha City, China (associated with Institute of Particle Physics, Central China Normal University, Wuhan, Hubei, China) Guangdong Provincial Key Laboratory of Nuclear Science, Guangdong-Hong Kong Joint Laboratory of Quantum Matter, Institute of Quantum Matter, South China Normal University, Guangzhou, China (associated with Center for High Energy Physics, Tsinghua University, Beijing, China) Lanzhou University, Lanzhou, China (associated with Institute Of High Energy Physics (IHEP), Beijing, China) School of Physics and Technology, Wuhan University, Wuhan, China (associated with Center for High Energy Physics, Tsinghua University, Beijing, China) Departamento de Fisica, Universidad Nacional de Colombia, Bogota, Colombia (associated with LPNHE, Sorbonne Université, Paris Diderot Sorbonne Paris Cité, CNRS/IN2P3, Paris, France) Universität Bonn - Helmholtz-Institut für Strahlen und Kernphysik, Bonn, Germany (associated with Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany) Eotvos Lorand University, Budapest, Hungary (associated with European Organization for Nuclear Research (CERN), Geneva, Switzerland) Van Swinderen Institute, University of Groningen, Groningen, Netherlands (associated with Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands) Universiteit Maastricht, Maastricht, Netherlands (associated with Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands) Tadeusz Kosciuszko Cracow University of Technology, Cracow, Poland (associated with Henryk Niewodniczanski Institute of Nuclear Physics Polish Academy of Sciences, Kraków, Poland) Department of Physics and Astronomy, Uppsala University, Uppsala, Sweden (associated with School of Physics and Astronomy, University of Glasgow, Glasgow, United Kingdom) University of Michigan, Ann Arbor, Michigan, USA (associated with Syracuse University, Syracuse, New York, USA) Departement de Physique Nucleaire (SPhN), Gif-Sur-Yvette, France
M P Blago Cavendish Laboratory, University of Cambridge, Cambridge, United Kingdom
T Blake Department of Physics, University of Warwick, Coventry, United Kingdom
F Blanc Institute of Physics, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland
J E Blank Fakultät Physik, Technische Universität Dortmund, Dortmund, Germany
S Blusk Syracuse University, Syracuse, New York, USA
D Bobulska School of Physics and Astronomy, University of Glasgow, Glasgow, United Kingdom
V Bocharnikov Affiliated with an institute covered by a cooperation agreement with CERN
J A Boelhauve Fakultät Physik, Technische Universität Dortmund, Dortmund, Germany
O Boente Garcia Laboratoire Leprince-Ringuet, CNRS/IN2P3, Ecole Polytechnique, Institut Polytechnique de Paris, Palaiseau, France
T Boettcher University of Cincinnati, Cincinnati, Ohio, USA
A Bohare School of Physics and Astronomy, University of Edinburgh, Edinburgh, United Kingdom
A Boldyrev Affiliated with an institute covered by a cooperation agreement with CERN
C S Bolognani Universiteit Maastricht, Maastricht, Netherlands (associated with Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands)
R Bolzonella INFN Sezione di Ferrara, Ferrara, Italy
N Bondar Affiliated with an institute covered by a cooperation agreement with CERN
F Borgato Università degli Studi di Padova, Università e INFN, Padova, Padova, Italy European Organization for Nuclear Research (CERN), Geneva, Switzerland
S Borghi Department of Physics and Astronomy, University of Manchester, Manchester, United Kingdom
M Borsato INFN Sezione di Milano-Bicocca, Milano, Italy
J T Borsuk Henryk Niewodniczanski Institute of Nuclear Physics Polish Academy of Sciences, Kraków, Poland
S A Bouchiba Institute of Physics, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland
T J V Bowcock Oliver Lodge Laboratory, University of Liverpool, Liverpool, United Kingdom
A Boyer European Organization for Nuclear Research (CERN), Geneva, Switzerland
C Bozzi INFN Sezione di Ferrara, Ferrara, Italy
M J Bradley Imperial College London, London, United Kingdom
S Braun University of Maryland, College Park, Maryland, USA
A Brea Rodriguez Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
N Breer Fakultät Physik, Technische Universität Dortmund, Dortmund, Germany
J Brodzicka Henryk Niewodniczanski Institute of Nuclear Physics Polish Academy of Sciences, Kraków, Poland
A Brossa Gonzalo Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
J Brown Oliver Lodge Laboratory, University of Liverpool, Liverpool, United Kingdom
D Brundu INFN Sezione di Cagliari, Monserrato, Italy
A Buonaura Physik-Institut, Universität Zürich, Zürich, Switzerland
L Buonincontri Università degli Studi di Padova, Università e INFN, Padova, Padova, Italy
A T Burke Department of Physics and Astronomy, University of Manchester, Manchester, United Kingdom
C Burr European Organization for Nuclear Research (CERN), Geneva, Switzerland
A Bursche Guangdong Provincial Key Laboratory of Nuclear Science, Guangdong-Hong Kong Joint Laboratory of Quantum Matter, Institute of Quantum Matter, South China Normal University, Guangzhou, China (associated with Center for High Energy Physics, Tsinghua University, Beijing, China)
A Butkevich Affiliated with an institute covered by a cooperation agreement with CERN
J S Butter Cavendish Laboratory, University of Cambridge, Cambridge, United Kingdom
J Buytaert European Organization for Nuclear Research (CERN), Geneva, Switzerland
W Byczynski European Organization for Nuclear Research (CERN), Geneva, Switzerland
S Cadeddu INFN Sezione di Cagliari, Monserrato, Italy
H Cai School of Physics and Technology, Wuhan University, Wuhan, China (associated with Center for High Energy Physics, Tsinghua University, Beijing, China)
R Calabrese INFN Sezione di Ferrara, Ferrara, Italy
L Calefice Fakultät Physik, Technische Universität Dortmund, Dortmund, Germany
S Cali INFN Laboratori Nazionali di Frascati, Frascati, Italy
M Calvi INFN Sezione di Milano-Bicocca, Milano, Italy
M Calvo Gomez DS4DS, La Salle, Universitat Ramon Llull, Barcelona, Spain
J Cambon Bouzas Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
P Campana INFN Laboratori Nazionali di Frascati, Frascati, Italy
D H Campora Perez Universiteit Maastricht, Maastricht, Netherlands (associated with Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands)
A F Campoverde Quezada University of Chinese Academy of Sciences, Beijing, China
S Capelli INFN Sezione di Milano-Bicocca, Milano, Italy
L Capriotti INFN Sezione di Ferrara, Ferrara, Italy
R Caravaca-Mora Consejo Nacional de Rectores (CONARE), San Jose, Costa Rica
A Carbone INFN Sezione di Bologna, Bologna, Italy
L Carcedo Salgado Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
R Cardinale INFN Sezione di Genova, Genova, Italy
A Cardini INFN Sezione di Cagliari, Monserrato, Italy
P Carniti INFN Sezione di Milano-Bicocca, Milano, Italy
L Carus Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
A Casais Vidal Massachusetts Institute of Technology, Cambridge, Massachusetts, USA
R Caspary Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
G Casse Oliver Lodge Laboratory, University of Liverpool, Liverpool, United Kingdom
J Castro Godinez Consejo Nacional de Rectores (CONARE), San Jose, Costa Rica
M Cattaneo European Organization for Nuclear Research (CERN), Geneva, Switzerland
G Cavallero INFN Sezione di Ferrara, Ferrara, Italy
V Cavallini INFN Sezione di Ferrara, Ferrara, Italy
S Celani Institute of Physics, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland
J Cerasoli Aix Marseille Univ, CNRS/IN2P3, CPPM, Marseille, France
D Cervenkov Department of Physics, University of Oxford, Oxford, United Kingdom
S Cesare INFN Sezione di Milano, Milano, Italy
A J Chadwick Oliver Lodge Laboratory, University of Liverpool, Liverpool, United Kingdom
I Chahrour University of Michigan, Ann Arbor, Michigan, USA (associated with Syracuse University, Syracuse, New York, USA)
M Charles LPNHE, Sorbonne Université, Paris Diderot Sorbonne Paris Cité, CNRS/IN2P3, Paris, France
Ph Charpentier European Organization for Nuclear Research (CERN), Geneva, Switzerland
C A Chavez Barajas Oliver Lodge Laboratory, University of Liverpool, Liverpool, United Kingdom
M Chefdeville Université Savoie Mont Blanc, CNRS, IN2P3-LAPP, Annecy, France
C Chen Aix Marseille Univ, CNRS/IN2P3, CPPM, Marseille, France
S Chen Institute Of High Energy Physics (IHEP), Beijing, China
A Chernov Henryk Niewodniczanski Institute of Nuclear Physics Polish Academy of Sciences, Kraków, Poland
S Chernyshenko Institute for Nuclear Research of the National Academy of Sciences (KINR), Kyiv, Ukraine
V Chobanova Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
S Cholak Institute of Physics, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland
M Chrzaszcz Henryk Niewodniczanski Institute of Nuclear Physics Polish Academy of Sciences, Kraków, Poland
A Chubykin Affiliated with an institute covered by a cooperation agreement with CERN
V Chulikov Affiliated with an institute covered by a cooperation agreement with CERN
P Ciambrone INFN Laboratori Nazionali di Frascati, Frascati, Italy
M F Cicala Department of Physics, University of Warwick, Coventry, United Kingdom
X Cid Vidal Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
G Ciezarek European Organization for Nuclear Research (CERN), Geneva, Switzerland
P Cifra European Organization for Nuclear Research (CERN), Geneva, Switzerland
P E L Clarke School of Physics and Astronomy, University of Edinburgh, Edinburgh, United Kingdom
M Clemencic European Organization for Nuclear Research (CERN), Geneva, Switzerland
H V Cliff Cavendish Laboratory, University of Cambridge, Cambridge, United Kingdom
J Closier European Organization for Nuclear Research (CERN), Geneva, Switzerland
J L Cobbledick Department of Physics and Astronomy, University of Manchester, Manchester, United Kingdom
C Cocha Toapaxi Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
V Coco European Organization for Nuclear Research (CERN), Geneva, Switzerland
J Cogan Aix Marseille Univ, CNRS/IN2P3, CPPM, Marseille, France
E Cogneras Université Clermont Auvergne, CNRS/IN2P3, LPC, Clermont-Ferrand, France
L Cojocariu Horia Hulubei National Institute of Physics and Nuclear Engineering, Bucharest-Magurele, Romania
P Collins European Organization for Nuclear Research (CERN), Geneva, Switzerland
T Colombo European Organization for Nuclear Research (CERN), Geneva, Switzerland
A Comerma-Montells ICCUB, Universitat de Barcelona, Barcelona, Spain
L Congedo INFN Sezione di Bari, Bari, Italy
A Contu INFN Sezione di Cagliari, Monserrato, Italy
N Cooke School of Physics and Astronomy, University of Glasgow, Glasgow, United Kingdom
I Corredoira Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
A Correia LPNHE, Sorbonne Université, Paris Diderot Sorbonne Paris Cité, CNRS/IN2P3, Paris, France
G Corti European Organization for Nuclear Research (CERN), Geneva, Switzerland
J J Cottee Meldrum H.H. Wills Physics Laboratory, University of Bristol, Bristol, United Kingdom
B Couturier European Organization for Nuclear Research (CERN), Geneva, Switzerland
D C Craik Physik-Institut, Universität Zürich, Zürich, Switzerland
M Cruz Torres Centro Brasileiro de Pesquisas Físicas (CBPF), Rio de Janeiro, Brazil
R Currie School of Physics and Astronomy, University of Edinburgh, Edinburgh, United Kingdom
C L Da Silva Los Alamos National Laboratory (LANL), Los Alamos, New Mexico, USA
S Dadabaev Affiliated with an institute covered by a cooperation agreement with CERN
L Dai School of Physics and Electronics, Hunan University, Changsha City, China (associated with Institute of Particle Physics, Central China Normal University, Wuhan, Hubei, China)
X Dai School of Physics State Key Laboratory of Nuclear Physics and Technology, Peking University, Beijing, China
E Dall'Occo Fakultät Physik, Technische Universität Dortmund, Dortmund, Germany
J Dalseno Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
C D'Ambrosio European Organization for Nuclear Research (CERN), Geneva, Switzerland
J Daniel Université Clermont Auvergne, CNRS/IN2P3, LPC, Clermont-Ferrand, France
A Danilina Affiliated with an institute covered by a cooperation agreement with CERN
P d'Argent INFN Sezione di Bari, Bari, Italy
A Davidson Department of Physics, University of Warwick, Coventry, United Kingdom
J E Davies Department of Physics and Astronomy, University of Manchester, Manchester, United Kingdom
A Davis Department of Physics and Astronomy, University of Manchester, Manchester, United Kingdom
O De Aguiar Francisco Department of Physics and Astronomy, University of Manchester, Manchester, United Kingdom
C De Angelis INFN Sezione di Cagliari, Monserrato, Italy
J de Boer Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands
K De Bruyn Van Swinderen Institute, University of Groningen, Groningen, Netherlands (associated with Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands)
S De Capua Department of Physics and Astronomy, University of Manchester, Manchester, United Kingdom
M De Cian Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany European Organization for Nuclear Research (CERN), Geneva, Switzerland
U De Freitas Carneiro Da Graca Centro Brasileiro de Pesquisas Físicas (CBPF), Rio de Janeiro, Brazil
E De Lucia INFN Laboratori Nazionali di Frascati, Frascati, Italy
J M De Miranda Centro Brasileiro de Pesquisas Físicas (CBPF), Rio de Janeiro, Brazil
L De Paula Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil
M De Serio INFN Sezione di Bari, Bari, Italy
D De Simone Physik-Institut, Universität Zürich, Zürich, Switzerland
P De Simone INFN Laboratori Nazionali di Frascati, Frascati, Italy
F De Vellis Fakultät Physik, Technische Universität Dortmund, Dortmund, Germany
J A de Vries Universiteit Maastricht, Maastricht, Netherlands (associated with Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands)
F Debernardis INFN Sezione di Bari, Bari, Italy
D Decamp Université Savoie Mont Blanc, CNRS, IN2P3-LAPP, Annecy, France
V Dedu Aix Marseille Univ, CNRS/IN2P3, CPPM, Marseille, France
L Del Buono LPNHE, Sorbonne Université, Paris Diderot Sorbonne Paris Cité, CNRS/IN2P3, Paris, France
B Delaney Massachusetts Institute of Technology, Cambridge, Massachusetts, USA
H-P Dembinski Fakultät Physik, Technische Universität Dortmund, Dortmund, Germany
J Deng Institute of Particle Physics, Central China Normal University, Wuhan, Hubei, China
V Denysenko Physik-Institut, Universität Zürich, Zürich, Switzerland
O Deschamps Université Clermont Auvergne, CNRS/IN2P3, LPC, Clermont-Ferrand, France
F Dettori INFN Sezione di Cagliari, Monserrato, Italy
B Dey Eotvos Lorand University, Budapest, Hungary (associated with European Organization for Nuclear Research (CERN), Geneva, Switzerland)
P Di Nezza INFN Laboratori Nazionali di Frascati, Frascati, Italy
I Diachkov Affiliated with an institute covered by a cooperation agreement with CERN
S Didenko Affiliated with an institute covered by a cooperation agreement with CERN
S Ding Syracuse University, Syracuse, New York, USA
V Dobishuk Institute for Nuclear Research of the National Academy of Sciences (KINR), Kyiv, Ukraine
A D Docheva School of Physics and Astronomy, University of Glasgow, Glasgow, United Kingdom
A Dolmatov Affiliated with an institute covered by a cooperation agreement with CERN
C Dong Center for High Energy Physics, Tsinghua University, Beijing, China
A M Donohoe School of Physics, University College Dublin, Dublin, Ireland
F Dordei INFN Sezione di Cagliari, Monserrato, Italy
A C Dos Reis Centro Brasileiro de Pesquisas Físicas (CBPF), Rio de Janeiro, Brazil
L Douglas School of Physics and Astronomy, University of Glasgow, Glasgow, United Kingdom
A G Downes Université Savoie Mont Blanc, CNRS, IN2P3-LAPP, Annecy, France
W Duan Guangdong Provincial Key Laboratory of Nuclear Science, Guangdong-Hong Kong Joint Laboratory of Quantum Matter, Institute of Quantum Matter, South China Normal University, Guangzhou, China (associated with Center for High Energy Physics, Tsinghua University, Beijing, China)
P Duda Tadeusz Kosciuszko Cracow University of Technology, Cracow, Poland (associated with Henryk Niewodniczanski Institute of Nuclear Physics Polish Academy of Sciences, Kraków, Poland)
M W Dudek Henryk Niewodniczanski Institute of Nuclear Physics Polish Academy of Sciences, Kraków, Poland
L Dufour European Organization for Nuclear Research (CERN), Geneva, Switzerland
V Duk INFN Sezione di Perugia, Perugia, Italy
P Durante European Organization for Nuclear Research (CERN), Geneva, Switzerland
M M Duras Tadeusz Kosciuszko Cracow University of Technology, Cracow, Poland (associated with Henryk Niewodniczanski Institute of Nuclear Physics Polish Academy of Sciences, Kraków, Poland)
J M Durham Los Alamos National Laboratory (LANL), Los Alamos, New Mexico, USA
A Dziurda Henryk Niewodniczanski Institute of Nuclear Physics Polish Academy of Sciences, Kraków, Poland
A Dzyuba Affiliated with an institute covered by a cooperation agreement with CERN
S Easo European Organization for Nuclear Research (CERN), Geneva, Switzerland STFC Rutherford Appleton Laboratory, Didcot, United Kingdom
E Eckstein Universität Bonn - Helmholtz-Institut für Strahlen und Kernphysik, Bonn, Germany (associated with Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany)
U Egede School of Physics and Astronomy, Monash University, Melbourne, Australia
A Egorychev Affiliated with an institute covered by a cooperation agreement with CERN
V Egorychev Affiliated with an institute covered by a cooperation agreement with CERN
C Eirea Orro Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
S Eisenhardt School of Physics and Astronomy, University of Edinburgh, Edinburgh, United Kingdom
E Ejopu Department of Physics and Astronomy, University of Manchester, Manchester, United Kingdom
S Ek-In Institute of Physics, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland
L Eklund Department of Physics and Astronomy, Uppsala University, Uppsala, Sweden (associated with School of Physics and Astronomy, University of Glasgow, Glasgow, United Kingdom)
M Elashri University of Cincinnati, Cincinnati, Ohio, USA
J Ellbracht Fakultät Physik, Technische Universität Dortmund, Dortmund, Germany
S Ely Imperial College London, London, United Kingdom
A Ene Horia Hulubei National Institute of Physics and Nuclear Engineering, Bucharest-Magurele, Romania
E Epple University of Cincinnati, Cincinnati, Ohio, USA
S Escher I. Physikalisches Institut, RWTH Aachen University, Aachen, Germany
J Eschle Physik-Institut, Universität Zürich, Zürich, Switzerland
S Esen Physik-Institut, Universität Zürich, Zürich, Switzerland
T Evans Department of Physics and Astronomy, University of Manchester, Manchester, United Kingdom
F Fabiano INFN Sezione di Cagliari, Monserrato, Italy European Organization for Nuclear Research (CERN), Geneva, Switzerland
L N Falcao Centro Brasileiro de Pesquisas Físicas (CBPF), Rio de Janeiro, Brazil
Y Fan University of Chinese Academy of Sciences, Beijing, China
B Fang Université Paris-Saclay, CNRS/IN2P3, IJCLab, Orsay, France School of Physics and Technology, Wuhan University, Wuhan, China (associated with Center for High Energy Physics, Tsinghua University, Beijing, China)
L Fantini INFN Sezione di Perugia, Perugia, Italy
M Faria Institute of Physics, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland
K Farmer School of Physics and Astronomy, University of Edinburgh, Edinburgh, United Kingdom
D Fazzini INFN Sezione di Milano-Bicocca, Milano, Italy
L Felkowski Tadeusz Kosciuszko Cracow University of Technology, Cracow, Poland (associated with Henryk Niewodniczanski Institute of Nuclear Physics Polish Academy of Sciences, Kraków, Poland)
M Feng Institute Of High Energy Physics (IHEP), Beijing, China University of Chinese Academy of Sciences, Beijing, China
M Feo European Organization for Nuclear Research (CERN), Geneva, Switzerland
M Fernandez Gomez Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
A D Fernez University of Maryland, College Park, Maryland, USA
F Ferrari INFN Sezione di Bologna, Bologna, Italy
F Ferreira Rodrigues Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil
S Ferreres Sole Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands
M Ferrillo Physik-Institut, Universität Zürich, Zürich, Switzerland
M Ferro-Luzzi European Organization for Nuclear Research (CERN), Geneva, Switzerland
S Filippov Affiliated with an institute covered by a cooperation agreement with CERN
R A Fini INFN Sezione di Bari, Bari, Italy
M Fiorini INFN Sezione di Ferrara, Ferrara, Italy
M Firlej AGH - University of Science and Technology, Faculty of Physics and Applied Computer Science, Kraków, Poland
K M Fischer Department of Physics, University of Oxford, Oxford, United Kingdom
D S Fitzgerald University of Michigan, Ann Arbor, Michigan, USA (associated with Syracuse University, Syracuse, New York, USA)
C Fitzpatrick Department of Physics and Astronomy, University of Manchester, Manchester, United Kingdom
T Fiutowski AGH - University of Science and Technology, Faculty of Physics and Applied Computer Science, Kraków, Poland
F Fleuret Laboratoire Leprince-Ringuet, CNRS/IN2P3, Ecole Polytechnique, Institut Polytechnique de Paris, Palaiseau, France
M Fontana INFN Sezione di Bologna, Bologna, Italy
F Fontanelli INFN Sezione di Genova, Genova, Italy
L F Foreman Department of Physics and Astronomy, University of Manchester, Manchester, United Kingdom
R Forty European Organization for Nuclear Research (CERN), Geneva, Switzerland
D Foulds-Holt Cavendish Laboratory, University of Cambridge, Cambridge, United Kingdom
M Franco Sevilla University of Maryland, College Park, Maryland, USA
M Frank European Organization for Nuclear Research (CERN), Geneva, Switzerland
E Franzoso INFN Sezione di Ferrara, Ferrara, Italy
G Frau Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
C Frei European Organization for Nuclear Research (CERN), Geneva, Switzerland
D A Friday Department of Physics and Astronomy, University of Manchester, Manchester, United Kingdom
L Frontini INFN Sezione di Milano, Milano, Italy
J Fu University of Chinese Academy of Sciences, Beijing, China
Q Fuehring Fakultät Physik, Technische Universität Dortmund, Dortmund, Germany
Y Fujii School of Physics and Astronomy, Monash University, Melbourne, Australia
T Fulghesu LPNHE, Sorbonne Université, Paris Diderot Sorbonne Paris Cité, CNRS/IN2P3, Paris, France
E Gabriel Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands
G Galati INFN Sezione di Bari, Bari, Italy
M D Galati Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands
A Gallas Torreira Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
D Galli INFN Sezione di Bologna, Bologna, Italy
S Gambetta European Organization for Nuclear Research (CERN), Geneva, Switzerland School of Physics and Astronomy, University of Edinburgh, Edinburgh, United Kingdom
M Gandelman Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil
P Gandini INFN Sezione di Milano, Milano, Italy
H Gao University of Chinese Academy of Sciences, Beijing, China
R Gao Department of Physics, University of Oxford, Oxford, United Kingdom
Y Gao Institute of Particle Physics, Central China Normal University, Wuhan, Hubei, China
Y Gao School of Physics State Key Laboratory of Nuclear Physics and Technology, Peking University, Beijing, China
Y Gao Institute of Particle Physics, Central China Normal University, Wuhan, Hubei, China
M Garau INFN Sezione di Cagliari, Monserrato, Italy
L M Garcia Martin Institute of Physics, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland
P Garcia Moreno ICCUB, Universitat de Barcelona, Barcelona, Spain
J García Pardiñas European Organization for Nuclear Research (CERN), Geneva, Switzerland
B Garcia Plana Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
K G Garg Institute of Particle Physics, Central China Normal University, Wuhan, Hubei, China
L Garrido ICCUB, Universitat de Barcelona, Barcelona, Spain
C Gaspar European Organization for Nuclear Research (CERN), Geneva, Switzerland
R E Geertsema Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands
L L Gerken Fakultät Physik, Technische Universität Dortmund, Dortmund, Germany
E Gersabeck Department of Physics and Astronomy, University of Manchester, Manchester, United Kingdom
M Gersabeck Department of Physics and Astronomy, University of Manchester, Manchester, United Kingdom
T Gershon Department of Physics, University of Warwick, Coventry, United Kingdom
Z Ghorbanimoghaddam H.H. Wills Physics Laboratory, University of Bristol, Bristol, United Kingdom
L Giambastiani Università degli Studi di Padova, Università e INFN, Padova, Padova, Italy
F I Giasemis LPNHE, Sorbonne Université, Paris Diderot Sorbonne Paris Cité, CNRS/IN2P3, Paris, France
V Gibson Cavendish Laboratory, University of Cambridge, Cambridge, United Kingdom
H K Giemza National Center for Nuclear Research (NCBJ), Warsaw, Poland
A L Gilman Department of Physics, University of Oxford, Oxford, United Kingdom
M Giovannetti INFN Laboratori Nazionali di Frascati, Frascati, Italy
A Gioventù ICCUB, Universitat de Barcelona, Barcelona, Spain
P Gironella Gironell ICCUB, Universitat de Barcelona, Barcelona, Spain
C Giugliano INFN Sezione di Ferrara, Ferrara, Italy
M A Giza Henryk Niewodniczanski Institute of Nuclear Physics Polish Academy of Sciences, Kraków, Poland
E L Gkougkousis Imperial College London, London, United Kingdom
F C Glaser Université Paris-Saclay, CNRS/IN2P3, IJCLab, Orsay, France Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
V V Gligorov LPNHE, Sorbonne Université, Paris Diderot Sorbonne Paris Cité, CNRS/IN2P3, Paris, France
C Göbel Pontifícia Universidade Católica do Rio de Janeiro (PUC-Rio), Rio de Janeiro, Brazil (associated with Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil)
E Golobardes DS4DS, La Salle, Universitat Ramon Llull, Barcelona, Spain
D Golubkov Affiliated with an institute covered by a cooperation agreement with CERN
A Golutvin Affiliated with an institute covered by a cooperation agreement with CERN European Organization for Nuclear Research (CERN), Geneva, Switzerland Imperial College London, London, United Kingdom
A Gomes Centro Brasileiro de Pesquisas Físicas (CBPF), Rio de Janeiro, Brazil
S Gomez Fernandez ICCUB, Universitat de Barcelona, Barcelona, Spain
F Goncalves Abrantes Department of Physics, University of Oxford, Oxford, United Kingdom
M Goncerz Henryk Niewodniczanski Institute of Nuclear Physics Polish Academy of Sciences, Kraków, Poland
G Gong Center for High Energy Physics, Tsinghua University, Beijing, China
J A Gooding Fakultät Physik, Technische Universität Dortmund, Dortmund, Germany
I V Gorelov Affiliated with an institute covered by a cooperation agreement with CERN
C Gotti INFN Sezione di Milano-Bicocca, Milano, Italy
J P Grabowski Universität Bonn - Helmholtz-Institut für Strahlen und Kernphysik, Bonn, Germany (associated with Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany)
L A Granado Cardoso European Organization for Nuclear Research (CERN), Geneva, Switzerland
E Graugés ICCUB, Universitat de Barcelona, Barcelona, Spain
E Graverini Institute of Physics, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland
L Grazette Department of Physics, University of Warwick, Coventry, United Kingdom
G Graziani School of Physics and Astronomy, Monash University, Melbourne, Australia Centro Brasileiro de Pesquisas Físicas (CBPF), Rio de Janeiro, Brazil Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil Center for High Energy Physics, Tsinghua University, Beijing, China Institute Of High Energy Physics (IHEP), Beijing, China School of Physics State Key Laboratory of Nuclear Physics and Technology, Peking University, Beijing, China University of Chinese Academy of Sciences, Beijing, China Institute of Particle Physics, Central China Normal University, Wuhan, Hubei, China Consejo Nacional de Rectores (CONARE), San Jose, Costa Rica Université Savoie Mont Blanc, CNRS, IN2P3-LAPP, Annecy, France Université Clermont Auvergne, CNRS/IN2P3, LPC, Clermont-Ferrand, France Aix Marseille Univ, CNRS/IN2P3, CPPM, Marseille, France Université Paris-Saclay, CNRS/IN2P3, IJCLab, Orsay, France Laboratoire Leprince-Ringuet, CNRS/IN2P3, Ecole Polytechnique, Institut Polytechnique de Paris, Palaiseau, France LPNHE, Sorbonne Université, Paris Diderot Sorbonne Paris Cité, CNRS/IN2P3, Paris, France I. Physikalisches Institut, RWTH Aachen University, Aachen, Germany Fakultät Physik, Technische Universität Dortmund, Dortmund, Germany Max-Planck-Institut für Kernphysik (MPIK), Heidelberg, Germany Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany School of Physics, University College Dublin, Dublin, Ireland INFN Sezione di Bari, Bari, Italy INFN Sezione di Bologna, Bologna, Italy INFN Sezione di Ferrara, Ferrara, Italy INFN Sezione di Firenze, Firenze, Italy INFN Laboratori Nazionali di Frascati, Frascati, Italy INFN Sezione di Genova, Genova, Italy INFN Sezione di Milano, Milano, Italy INFN Sezione di Milano-Bicocca, Milano, Italy INFN Sezione di Cagliari, Monserrato, Italy Università degli Studi di Padova, Università e INFN, Padova, Padova, Italy INFN Sezione di Perugia, Perugia, Italy INFN Sezione di Pisa, Pisa, Italy INFN Sezione di Roma La Sapienza, Roma, Italy INFN Sezione di Roma Tor Vergata, Roma, Italy Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands Nikhef National Institute for Subatomic Physics and VU University Amsterdam, Amsterdam, Netherlands AGH - University of Science and Technology, Faculty of Physics and Applied Computer Science, Kraków, Poland Henryk Niewodniczanski Institute of Nuclear Physics Polish Academy of Sciences, Kraków, Poland National Center for Nuclear Research (NCBJ), Warsaw, Poland Horia Hulubei National Institute of Physics and Nuclear Engineering, Bucharest-Magurele, Romania Affiliated with an institute covered by a cooperation agreement with CERN DS4DS, La Salle, Universitat Ramon Llull, Barcelona, Spain ICCUB, Universitat de Barcelona, Barcelona, Spain Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain Instituto de Fisica Corpuscular, Centro Mixto Universidad de Valencia - CSIC, Valencia, Spain European Organization for Nuclear Research (CERN), Geneva, Switzerland Institute of Physics, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland Physik-Institut, Universität Zürich, Zürich, Switzerland NSC Kharkiv Institute of Physics and Technology (NSC KIPT), Kharkiv, Ukraine Institute for Nuclear Research of the National Academy of Sciences (KINR), Kyiv, Ukraine University of Birmingham, Birmingham, United Kingdom H.H. Wills Physics Laboratory, University of Bristol, Bristol, United Kingdom Cavendish Laboratory, University of Cambridge, Cambridge, United Kingdom Department of Physics, University of Warwick, Coventry, United Kingdom STFC Rutherford Appleton Laboratory, Didcot, United Kingdom School of Physics and Astronomy, University of Edinburgh, Edinburgh, United Kingdom School of Physics and Astronomy, University of Glasgow, Glasgow, United Kingdom Oliver Lodge Laboratory, University of Liverpool, Liverpool, United Kingdom Imperial College London, London, United Kingdom Department of Physics and Astronomy, University of Manchester, Manchester, United Kingdom Department of Physics, University of Oxford, Oxford, United Kingdom Massachusetts Institute of Technology, Cambridge, Massachusetts, USA University of Cincinnati, Cincinnati, Ohio, USA University of Maryland, College Park, Maryland, USA Los Alamos National Laboratory (LANL), Los Alamos, New Mexico, USA Syracuse University, Syracuse, New York, USA Pontifícia Universidade Católica do Rio de Janeiro (PUC-Rio), Rio de Janeiro, Brazil (associated with Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil) School of Physics and Electronics, Hunan University, Changsha City, China (associated with Institute of Particle Physics, Central China Normal University, Wuhan, Hubei, China) Guangdong Provincial Key Laboratory of Nuclear Science, Guangdong-Hong Kong Joint Laboratory of Quantum Matter, Institute of Quantum Matter, South China Normal University, Guangzhou, China (associated with Center for High Energy Physics, Tsinghua University, Beijing, China) Lanzhou University, Lanzhou, China (associated with Institute Of High Energy Physics (IHEP), Beijing, China) School of Physics and Technology, Wuhan University, Wuhan, China (associated with Center for High Energy Physics, Tsinghua University, Beijing, China) Departamento de Fisica, Universidad Nacional de Colombia, Bogota, Colombia (associated with LPNHE, Sorbonne Université, Paris Diderot Sorbonne Paris Cité, CNRS/IN2P3, Paris, France) Universität Bonn - Helmholtz-Institut für Strahlen und Kernphysik, Bonn, Germany (associated with Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany) Eotvos Lorand University, Budapest, Hungary (associated with European Organization for Nuclear Research (CERN), Geneva, Switzerland) Van Swinderen Institute, University of Groningen, Groningen, Netherlands (associated with Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands) Universiteit Maastricht, Maastricht, Netherlands (associated with Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands) Tadeusz Kosciuszko Cracow University of Technology, Cracow, Poland (associated with Henryk Niewodniczanski Institute of Nuclear Physics Polish Academy of Sciences, Kraków, Poland) Department of Physics and Astronomy, Uppsala University, Uppsala, Sweden (associated with School of Physics and Astronomy, University of Glasgow, Glasgow, United Kingdom) University of Michigan, Ann Arbor, Michigan, USA (associated with Syracuse University, Syracuse, New York, USA) Departement de Physique Nucleaire (SPhN), Gif-Sur-Yvette, France
A T Grecu Horia Hulubei National Institute of Physics and Nuclear Engineering, Bucharest-Magurele, Romania
L M Greeven Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands
N A Grieser University of Cincinnati, Cincinnati, Ohio, USA
L Grillo School of Physics and Astronomy, University of Glasgow, Glasgow, United Kingdom
S Gromov Affiliated with an institute covered by a cooperation agreement with CERN
C Gu Laboratoire Leprince-Ringuet, CNRS/IN2P3, Ecole Polytechnique, Institut Polytechnique de Paris, Palaiseau, France
M Guarise INFN Sezione di Ferrara, Ferrara, Italy
M Guittiere Université Paris-Saclay, CNRS/IN2P3, IJCLab, Orsay, France
V Guliaeva Affiliated with an institute covered by a cooperation agreement with CERN
P A Günther Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
A-K Guseinov Affiliated with an institute covered by a cooperation agreement with CERN
E Gushchin Affiliated with an institute covered by a cooperation agreement with CERN
Y Guz School of Physics State Key Laboratory of Nuclear Physics and Technology, Peking University, Beijing, China Affiliated with an institute covered by a cooperation agreement with CERN European Organization for Nuclear Research (CERN), Geneva, Switzerland
T Gys European Organization for Nuclear Research (CERN), Geneva, Switzerland
T Hadavizadeh School of Physics and Astronomy, Monash University, Melbourne, Australia
C Hadjivasiliou University of Maryland, College Park, Maryland, USA
G Haefeli Institute of Physics, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland
C Haen European Organization for Nuclear Research (CERN), Geneva, Switzerland
J Haimberger European Organization for Nuclear Research (CERN), Geneva, Switzerland
M Hajheidari European Organization for Nuclear Research (CERN), Geneva, Switzerland
T Halewood-Leagas Oliver Lodge Laboratory, University of Liverpool, Liverpool, United Kingdom
M M Halvorsen European Organization for Nuclear Research (CERN), Geneva, Switzerland
P M Hamilton University of Maryland, College Park, Maryland, USA
J Hammerich Oliver Lodge Laboratory, University of Liverpool, Liverpool, United Kingdom
Q Han Institute of Particle Physics, Central China Normal University, Wuhan, Hubei, China
X Han Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
S Hansmann-Menzemer Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
L Hao University of Chinese Academy of Sciences, Beijing, China
N Harnew Department of Physics, University of Oxford, Oxford, United Kingdom
T Harrison Oliver Lodge Laboratory, University of Liverpool, Liverpool, United Kingdom
M Hartmann Université Paris-Saclay, CNRS/IN2P3, IJCLab, Orsay, France
C Hasse European Organization for Nuclear Research (CERN), Geneva, Switzerland
J He University of Chinese Academy of Sciences, Beijing, China
K Heijhoff Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands
F Hemmer European Organization for Nuclear Research (CERN), Geneva, Switzerland
C Henderson University of Cincinnati, Cincinnati, Ohio, USA
R D L Henderson School of Physics and Astronomy, Monash University, Melbourne, Australia Department of Physics, University of Warwick, Coventry, United Kingdom
A M Hennequin European Organization for Nuclear Research (CERN), Geneva, Switzerland
K Hennessy Oliver Lodge Laboratory, University of Liverpool, Liverpool, United Kingdom
L Henry Institute of Physics, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland
J Herd Imperial College London, London, United Kingdom
J Heuel I. Physikalisches Institut, RWTH Aachen University, Aachen, Germany
A Hicheur Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil
D Hill Institute of Physics, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland
S E Hollitt Fakultät Physik, Technische Universität Dortmund, Dortmund, Germany
J Horswill Department of Physics and Astronomy, University of Manchester, Manchester, United Kingdom
R Hou Institute of Particle Physics, Central China Normal University, Wuhan, Hubei, China
Y Hou Université Savoie Mont Blanc, CNRS, IN2P3-LAPP, Annecy, France
N Howarth Oliver Lodge Laboratory, University of Liverpool, Liverpool, United Kingdom
J Hu Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
J Hu Guangdong Provincial Key Laboratory of Nuclear Science, Guangdong-Hong Kong Joint Laboratory of Quantum Matter, Institute of Quantum Matter, South China Normal University, Guangzhou, China (associated with Center for High Energy Physics, Tsinghua University, Beijing, China)
W Hu School of Physics State Key Laboratory of Nuclear Physics and Technology, Peking University, Beijing, China
X Hu Center for High Energy Physics, Tsinghua University, Beijing, China
W Huang University of Chinese Academy of Sciences, Beijing, China
W Hulsbergen Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands
R J Hunter Department of Physics, University of Warwick, Coventry, United Kingdom
M Hushchyn Affiliated with an institute covered by a cooperation agreement with CERN
D Hutchcroft Oliver Lodge Laboratory, University of Liverpool, Liverpool, United Kingdom
M Idzik AGH - University of Science and Technology, Faculty of Physics and Applied Computer Science, Kraków, Poland
D Ilin Affiliated with an institute covered by a cooperation agreement with CERN
P Ilten University of Cincinnati, Cincinnati, Ohio, USA
A Inglessi Affiliated with an institute covered by a cooperation agreement with CERN
A Iniukhin Affiliated with an institute covered by a cooperation agreement with CERN
A Ishteev Affiliated with an institute covered by a cooperation agreement with CERN
K Ivshin Affiliated with an institute covered by a cooperation agreement with CERN
R Jacobsson European Organization for Nuclear Research (CERN), Geneva, Switzerland
H Jage I. Physikalisches Institut, RWTH Aachen University, Aachen, Germany
S J Jaimes Elles Instituto de Fisica Corpuscular, Centro Mixto Universidad de Valencia - CSIC, Valencia, Spain Departamento de Fisica, Universidad Nacional de Colombia, Bogota, Colombia (associated with LPNHE, Sorbonne Université, Paris Diderot Sorbonne Paris Cité, CNRS/IN2P3, Paris, France)
S Jakobsen European Organization for Nuclear Research (CERN), Geneva, Switzerland
E Jans Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands
B K Jashal Instituto de Fisica Corpuscular, Centro Mixto Universidad de Valencia - CSIC, Valencia, Spain
A Jawahery University of Maryland, College Park, Maryland, USA
V Jevtic Fakultät Physik, Technische Universität Dortmund, Dortmund, Germany
E Jiang University of Maryland, College Park, Maryland, USA
X Jiang Institute Of High Energy Physics (IHEP), Beijing, China University of Chinese Academy of Sciences, Beijing, China
Y Jiang University of Chinese Academy of Sciences, Beijing, China
Y J Jiang School of Physics State Key Laboratory of Nuclear Physics and Technology, Peking University, Beijing, China
M John Department of Physics, University of Oxford, Oxford, United Kingdom
D Johnson University of Birmingham, Birmingham, United Kingdom
C R Jones Cavendish Laboratory, University of Cambridge, Cambridge, United Kingdom
T P Jones Department of Physics, University of Warwick, Coventry, United Kingdom
S Joshi National Center for Nuclear Research (NCBJ), Warsaw, Poland
B Jost European Organization for Nuclear Research (CERN), Geneva, Switzerland
N Jurik European Organization for Nuclear Research (CERN), Geneva, Switzerland
I Juszczak Henryk Niewodniczanski Institute of Nuclear Physics Polish Academy of Sciences, Kraków, Poland
D Kaminaris Institute of Physics, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland
S Kandybei NSC Kharkiv Institute of Physics and Technology (NSC KIPT), Kharkiv, Ukraine
Y Kang Center for High Energy Physics, Tsinghua University, Beijing, China
M Karacson European Organization for Nuclear Research (CERN), Geneva, Switzerland
D Karpenkov Affiliated with an institute covered by a cooperation agreement with CERN
M Karpov Affiliated with an institute covered by a cooperation agreement with CERN
A M Kauniskangas Institute of Physics, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland
J W Kautz University of Cincinnati, Cincinnati, Ohio, USA
F Keizer European Organization for Nuclear Research (CERN), Geneva, Switzerland
D M Keller Syracuse University, Syracuse, New York, USA
M Kenzie Cavendish Laboratory, University of Cambridge, Cambridge, United Kingdom
T Ketel Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands
B Khanji Syracuse University, Syracuse, New York, USA
A Kharisova Affiliated with an institute covered by a cooperation agreement with CERN
S Kholodenko INFN Sezione di Pisa, Pisa, Italy
G Khreich Université Paris-Saclay, CNRS/IN2P3, IJCLab, Orsay, France
T Kirn I. Physikalisches Institut, RWTH Aachen University, Aachen, Germany
V S Kirsebom Institute of Physics, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland
O Kitouni Massachusetts Institute of Technology, Cambridge, Massachusetts, USA
S Klaver Nikhef National Institute for Subatomic Physics and VU University Amsterdam, Amsterdam, Netherlands
N Kleijne INFN Sezione di Pisa, Pisa, Italy
K Klimaszewski National Center for Nuclear Research (NCBJ), Warsaw, Poland
M R Kmiec National Center for Nuclear Research (NCBJ), Warsaw, Poland
S Koliiev Institute for Nuclear Research of the National Academy of Sciences (KINR), Kyiv, Ukraine
L Kolk Fakultät Physik, Technische Universität Dortmund, Dortmund, Germany
A Konoplyannikov Affiliated with an institute covered by a cooperation agreement with CERN
P Kopciewicz AGH - University of Science and Technology, Faculty of Physics and Applied Computer Science, Kraków, Poland European Organization for Nuclear Research (CERN), Geneva, Switzerland
P Koppenburg Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands
M Korolev Affiliated with an institute covered by a cooperation agreement with CERN
I Kostiuk Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands
O Kot Institute for Nuclear Research of the National Academy of Sciences (KINR), Kyiv, Ukraine
S Kotriakhova School of Physics and Astronomy, Monash University, Melbourne, Australia Centro Brasileiro de Pesquisas Físicas (CBPF), Rio de Janeiro, Brazil Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil Center for High Energy Physics, Tsinghua University, Beijing, China Institute Of High Energy Physics (IHEP), Beijing, China School of Physics State Key Laboratory of Nuclear Physics and Technology, Peking University, Beijing, China University of Chinese Academy of Sciences, Beijing, China Institute of Particle Physics, Central China Normal University, Wuhan, Hubei, China Consejo Nacional de Rectores (CONARE), San Jose, Costa Rica Université Savoie Mont Blanc, CNRS, IN2P3-LAPP, Annecy, France Université Clermont Auvergne, CNRS/IN2P3, LPC, Clermont-Ferrand, France Aix Marseille Univ, CNRS/IN2P3, CPPM, Marseille, France Université Paris-Saclay, CNRS/IN2P3, IJCLab, Orsay, France Laboratoire Leprince-Ringuet, CNRS/IN2P3, Ecole Polytechnique, Institut Polytechnique de Paris, Palaiseau, France LPNHE, Sorbonne Université, Paris Diderot Sorbonne Paris Cité, CNRS/IN2P3, Paris, France I. Physikalisches Institut, RWTH Aachen University, Aachen, Germany Fakultät Physik, Technische Universität Dortmund, Dortmund, Germany Max-Planck-Institut für Kernphysik (MPIK), Heidelberg, Germany Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany School of Physics, University College Dublin, Dublin, Ireland INFN Sezione di Bari, Bari, Italy INFN Sezione di Bologna, Bologna, Italy INFN Sezione di Ferrara, Ferrara, Italy INFN Sezione di Firenze, Firenze, Italy INFN Laboratori Nazionali di Frascati, Frascati, Italy INFN Sezione di Genova, Genova, Italy INFN Sezione di Milano, Milano, Italy INFN Sezione di Milano-Bicocca, Milano, Italy INFN Sezione di Cagliari, Monserrato, Italy Università degli Studi di Padova, Università e INFN, Padova, Padova, Italy INFN Sezione di Perugia, Perugia, Italy INFN Sezione di Pisa, Pisa, Italy INFN Sezione di Roma La Sapienza, Roma, Italy INFN Sezione di Roma Tor Vergata, Roma, Italy Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands Nikhef National Institute for Subatomic Physics and VU University Amsterdam, Amsterdam, Netherlands AGH - University of Science and Technology, Faculty of Physics and Applied Computer Science, Kraków, Poland Henryk Niewodniczanski Institute of Nuclear Physics Polish Academy of Sciences, Kraków, Poland National Center for Nuclear Research (NCBJ), Warsaw, Poland Horia Hulubei National Institute of Physics and Nuclear Engineering, Bucharest-Magurele, Romania Affiliated with an institute covered by a cooperation agreement with CERN DS4DS, La Salle, Universitat Ramon Llull, Barcelona, Spain ICCUB, Universitat de Barcelona, Barcelona, Spain Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain Instituto de Fisica Corpuscular, Centro Mixto Universidad de Valencia - CSIC, Valencia, Spain European Organization for Nuclear Research (CERN), Geneva, Switzerland Institute of Physics, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland Physik-Institut, Universität Zürich, Zürich, Switzerland NSC Kharkiv Institute of Physics and Technology (NSC KIPT), Kharkiv, Ukraine Institute for Nuclear Research of the National Academy of Sciences (KINR), Kyiv, Ukraine University of Birmingham, Birmingham, United Kingdom H.H. Wills Physics Laboratory, University of Bristol, Bristol, United Kingdom Cavendish Laboratory, University of Cambridge, Cambridge, United Kingdom Department of Physics, University of Warwick, Coventry, United Kingdom STFC Rutherford Appleton Laboratory, Didcot, United Kingdom School of Physics and Astronomy, University of Edinburgh, Edinburgh, United Kingdom School of Physics and Astronomy, University of Glasgow, Glasgow, United Kingdom Oliver Lodge Laboratory, University of Liverpool, Liverpool, United Kingdom Imperial College London, London, United Kingdom Department of Physics and Astronomy, University of Manchester, Manchester, United Kingdom Department of Physics, University of Oxford, Oxford, United Kingdom Massachusetts Institute of Technology, Cambridge, Massachusetts, USA University of Cincinnati, Cincinnati, Ohio, USA University of Maryland, College Park, Maryland, USA Los Alamos National Laboratory (LANL), Los Alamos, New Mexico, USA Syracuse University, Syracuse, New York, USA Pontifícia Universidade Católica do Rio de Janeiro (PUC-Rio), Rio de Janeiro, Brazil (associated with Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil) School of Physics and Electronics, Hunan University, Changsha City, China (associated with Institute of Particle Physics, Central China Normal University, Wuhan, Hubei, China) Guangdong Provincial Key Laboratory of Nuclear Science, Guangdong-Hong Kong Joint Laboratory of Quantum Matter, Institute of Quantum Matter, South China Normal University, Guangzhou, China (associated with Center for High Energy Physics, Tsinghua University, Beijing, China) Lanzhou University, Lanzhou, China (associated with Institute Of High Energy Physics (IHEP), Beijing, China) School of Physics and Technology, Wuhan University, Wuhan, China (associated with Center for High Energy Physics, Tsinghua University, Beijing, China) Departamento de Fisica, Universidad Nacional de Colombia, Bogota, Colombia (associated with LPNHE, Sorbonne Université, Paris Diderot Sorbonne Paris Cité, CNRS/IN2P3, Paris, France) Universität Bonn - Helmholtz-Institut für Strahlen und Kernphysik, Bonn, Germany (associated with Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany) Eotvos Lorand University, Budapest, Hungary (associated with European Organization for Nuclear Research (CERN), Geneva, Switzerland) Van Swinderen Institute, University of Groningen, Groningen, Netherlands (associated with Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands) Universiteit Maastricht, Maastricht, Netherlands (associated with Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands) Tadeusz Kosciuszko Cracow University of Technology, Cracow, Poland (associated with Henryk Niewodniczanski Institute of Nuclear Physics Polish Academy of Sciences, Kraków, Poland) Department of Physics and Astronomy, Uppsala University, Uppsala, Sweden (associated with School of Physics and Astronomy, University of Glasgow, Glasgow, United Kingdom) University of Michigan, Ann Arbor, Michigan, USA (associated with Syracuse University, Syracuse, New York, USA) Departement de Physique Nucleaire (SPhN), Gif-Sur-Yvette, France
A Kozachuk Affiliated with an institute covered by a cooperation agreement with CERN
P Kravchenko Affiliated with an institute covered by a cooperation agreement with CERN
L Kravchuk Affiliated with an institute covered by a cooperation agreement with CERN
M Kreps Department of Physics, University of Warwick, Coventry, United Kingdom
S Kretzschmar I. Physikalisches Institut, RWTH Aachen University, Aachen, Germany
P Krokovny Affiliated with an institute covered by a cooperation agreement with CERN
W Krupa Syracuse University, Syracuse, New York, USA
W Krzemien National Center for Nuclear Research (NCBJ), Warsaw, Poland
J Kubat Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
S Kubis Tadeusz Kosciuszko Cracow University of Technology, Cracow, Poland (associated with Henryk Niewodniczanski Institute of Nuclear Physics Polish Academy of Sciences, Kraków, Poland)
W Kucewicz Henryk Niewodniczanski Institute of Nuclear Physics Polish Academy of Sciences, Kraków, Poland
M Kucharczyk Henryk Niewodniczanski Institute of Nuclear Physics Polish Academy of Sciences, Kraków, Poland
V Kudryavtsev Affiliated with an institute covered by a cooperation agreement with CERN
E Kulikova Affiliated with an institute covered by a cooperation agreement with CERN
A Kupsc Department of Physics and Astronomy, Uppsala University, Uppsala, Sweden (associated with School of Physics and Astronomy, University of Glasgow, Glasgow, United Kingdom)
B K Kutsenko Aix Marseille Univ, CNRS/IN2P3, CPPM, Marseille, France
D Lacarrere European Organization for Nuclear Research (CERN), Geneva, Switzerland
A Lai INFN Sezione di Cagliari, Monserrato, Italy
A Lampis INFN Sezione di Cagliari, Monserrato, Italy
D Lancierini Physik-Institut, Universität Zürich, Zürich, Switzerland
C Landesa Gomez Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
J J Lane School of Physics and Astronomy, Monash University, Melbourne, Australia
R Lane H.H. Wills Physics Laboratory, University of Bristol, Bristol, United Kingdom
C Langenbruch Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
J Langer Fakultät Physik, Technische Universität Dortmund, Dortmund, Germany
O Lantwin Affiliated with an institute covered by a cooperation agreement with CERN
T Latham Department of Physics, University of Warwick, Coventry, United Kingdom
F Lazzari INFN Sezione di Pisa, Pisa, Italy
C Lazzeroni University of Birmingham, Birmingham, United Kingdom
R Le Gac Aix Marseille Univ, CNRS/IN2P3, CPPM, Marseille, France
S H Lee University of Michigan, Ann Arbor, Michigan, USA (associated with Syracuse University, Syracuse, New York, USA)
R Lefèvre Université Clermont Auvergne, CNRS/IN2P3, LPC, Clermont-Ferrand, France
A Leflat Affiliated with an institute covered by a cooperation agreement with CERN
S Legotin Affiliated with an institute covered by a cooperation agreement with CERN
M Lehuraux Department of Physics, University of Warwick, Coventry, United Kingdom
O Leroy Aix Marseille Univ, CNRS/IN2P3, CPPM, Marseille, France
T Lesiak Henryk Niewodniczanski Institute of Nuclear Physics Polish Academy of Sciences, Kraków, Poland
B Leverington Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
A Li Center for High Energy Physics, Tsinghua University, Beijing, China
H Li Guangdong Provincial Key Laboratory of Nuclear Science, Guangdong-Hong Kong Joint Laboratory of Quantum Matter, Institute of Quantum Matter, South China Normal University, Guangzhou, China (associated with Center for High Energy Physics, Tsinghua University, Beijing, China)
K Li Institute of Particle Physics, Central China Normal University, Wuhan, Hubei, China
L Li Department of Physics and Astronomy, University of Manchester, Manchester, United Kingdom
P Li European Organization for Nuclear Research (CERN), Geneva, Switzerland
P-R Li Lanzhou University, Lanzhou, China (associated with Institute Of High Energy Physics (IHEP), Beijing, China)
S Li Institute of Particle Physics, Central China Normal University, Wuhan, Hubei, China
T Li Institute Of High Energy Physics (IHEP), Beijing, China
T Li Guangdong Provincial Key Laboratory of Nuclear Science, Guangdong-Hong Kong Joint Laboratory of Quantum Matter, Institute of Quantum Matter, South China Normal University, Guangzhou, China (associated with Center for High Energy Physics, Tsinghua University, Beijing, China)
Y Li Institute of Particle Physics, Central China Normal University, Wuhan, Hubei, China
Y Li Institute Of High Energy Physics (IHEP), Beijing, China
Z Li Syracuse University, Syracuse, New York, USA
Z Lian Center for High Energy Physics, Tsinghua University, Beijing, China
X Liang Syracuse University, Syracuse, New York, USA
C Lin University of Chinese Academy of Sciences, Beijing, China
T Lin STFC Rutherford Appleton Laboratory, Didcot, United Kingdom
R Lindner European Organization for Nuclear Research (CERN), Geneva, Switzerland
V Lisovskyi Institute of Physics, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland
R Litvinov INFN Sezione di Cagliari, Monserrato, Italy
G Liu Guangdong Provincial Key Laboratory of Nuclear Science, Guangdong-Hong Kong Joint Laboratory of Quantum Matter, Institute of Quantum Matter, South China Normal University, Guangzhou, China (associated with Center for High Energy Physics, Tsinghua University, Beijing, China)
H Liu University of Chinese Academy of Sciences, Beijing, China
K Liu Lanzhou University, Lanzhou, China (associated with Institute Of High Energy Physics (IHEP), Beijing, China)
Q Liu University of Chinese Academy of Sciences, Beijing, China
S Liu Institute Of High Energy Physics (IHEP), Beijing, China University of Chinese Academy of Sciences, Beijing, China
Y Liu School of Physics and Astronomy, University of Edinburgh, Edinburgh, United Kingdom
Y Liu Lanzhou University, Lanzhou, China (associated with Institute Of High Energy Physics (IHEP), Beijing, China)
Y L Liu Imperial College London, London, United Kingdom
A Lobo Salvia ICCUB, Universitat de Barcelona, Barcelona, Spain
A Loi INFN Sezione di Cagliari, Monserrato, Italy
J Lomba Castro Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
T Long Cavendish Laboratory, University of Cambridge, Cambridge, United Kingdom
J H Lopes Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil
A Lopez Huertas ICCUB, Universitat de Barcelona, Barcelona, Spain
S López Soliño Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
G H Lovell Cavendish Laboratory, University of Cambridge, Cambridge, United Kingdom
C Lucarelli INFN Sezione di Firenze, Firenze, Italy
D Lucchesi Università degli Studi di Padova, Università e INFN, Padova, Padova, Italy
S Luchuk Affiliated with an institute covered by a cooperation agreement with CERN
M Lucio Martinez Universiteit Maastricht, Maastricht, Netherlands (associated with Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands)
V Lukashenko Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands Institute for Nuclear Research of the National Academy of Sciences (KINR), Kyiv, Ukraine
Y Luo Center for High Energy Physics, Tsinghua University, Beijing, China
A Lupato Università degli Studi di Padova, Università e INFN, Padova, Padova, Italy
E Luppi INFN Sezione di Ferrara, Ferrara, Italy
K Lynch School of Physics, University College Dublin, Dublin, Ireland
X-R Lyu University of Chinese Academy of Sciences, Beijing, China
G M Ma Center for High Energy Physics, Tsinghua University, Beijing, China
R Ma University of Chinese Academy of Sciences, Beijing, China
S Maccolini Fakultät Physik, Technische Universität Dortmund, Dortmund, Germany
F Machefert Université Paris-Saclay, CNRS/IN2P3, IJCLab, Orsay, France
F Maciuc Horia Hulubei National Institute of Physics and Nuclear Engineering, Bucharest-Magurele, Romania
I Mackay Department of Physics, University of Oxford, Oxford, United Kingdom
L R Madhan Mohan Cavendish Laboratory, University of Cambridge, Cambridge, United Kingdom
M M Madurai University of Birmingham, Birmingham, United Kingdom
A Maevskiy Affiliated with an institute covered by a cooperation agreement with CERN
D Magdalinski Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands
D Maisuzenko Affiliated with an institute covered by a cooperation agreement with CERN
M W Majewski AGH - University of Science and Technology, Faculty of Physics and Applied Computer Science, Kraków, Poland
J J Malczewski Henryk Niewodniczanski Institute of Nuclear Physics Polish Academy of Sciences, Kraków, Poland
S Malde Department of Physics, University of Oxford, Oxford, United Kingdom
B Malecki Henryk Niewodniczanski Institute of Nuclear Physics Polish Academy of Sciences, Kraków, Poland European Organization for Nuclear Research (CERN), Geneva, Switzerland
L Malentacca European Organization for Nuclear Research (CERN), Geneva, Switzerland
A Malinin Affiliated with an institute covered by a cooperation agreement with CERN
T Maltsev Affiliated with an institute covered by a cooperation agreement with CERN
G Manca INFN Sezione di Cagliari, Monserrato, Italy
G Mancinelli Aix Marseille Univ, CNRS/IN2P3, CPPM, Marseille, France
C Mancuso Université Paris-Saclay, CNRS/IN2P3, IJCLab, Orsay, France INFN Sezione di Milano, Milano, Italy
R Manera Escalero ICCUB, Universitat de Barcelona, Barcelona, Spain
D Manuzzi INFN Sezione di Bologna, Bologna, Italy
D Marangotto INFN Sezione di Milano, Milano, Italy
J F Marchand Université Savoie Mont Blanc, CNRS, IN2P3-LAPP, Annecy, France
R Marchevski Institute of Physics, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland
U Marconi INFN Sezione di Bologna, Bologna, Italy
S Mariani European Organization for Nuclear Research (CERN), Geneva, Switzerland
C Marin Benito ICCUB, Universitat de Barcelona, Barcelona, Spain European Organization for Nuclear Research (CERN), Geneva, Switzerland
J Marks Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
A M Marshall H.H. Wills Physics Laboratory, University of Bristol, Bristol, United Kingdom
P J Marshall Oliver Lodge Laboratory, University of Liverpool, Liverpool, United Kingdom
G Martelli INFN Sezione di Perugia, Perugia, Italy
G Martellotti INFN Sezione di Roma La Sapienza, Roma, Italy
L Martinazzoli European Organization for Nuclear Research (CERN), Geneva, Switzerland
M Martinelli INFN Sezione di Milano-Bicocca, Milano, Italy
D Martinez Santos Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
F Martinez Vidal Instituto de Fisica Corpuscular, Centro Mixto Universidad de Valencia - CSIC, Valencia, Spain
A Massafferri Centro Brasileiro de Pesquisas Físicas (CBPF), Rio de Janeiro, Brazil
M Materok I. Physikalisches Institut, RWTH Aachen University, Aachen, Germany
R Matev European Organization for Nuclear Research (CERN), Geneva, Switzerland
A Mathad Physik-Institut, Universität Zürich, Zürich, Switzerland
V Matiunin Affiliated with an institute covered by a cooperation agreement with CERN
C Matteuzzi Syracuse University, Syracuse, New York, USA
K R Mattioli Laboratoire Leprince-Ringuet, CNRS/IN2P3, Ecole Polytechnique, Institut Polytechnique de Paris, Palaiseau, France
A Mauri Imperial College London, London, United Kingdom
E Maurice Laboratoire Leprince-Ringuet, CNRS/IN2P3, Ecole Polytechnique, Institut Polytechnique de Paris, Palaiseau, France
J Mauricio ICCUB, Universitat de Barcelona, Barcelona, Spain
P Mayencourt Institute of Physics, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland
M Mazurek European Organization for Nuclear Research (CERN), Geneva, Switzerland
M McCann Imperial College London, London, United Kingdom
L Mcconnell School of Physics, University College Dublin, Dublin, Ireland
T H McGrath Department of Physics and Astronomy, University of Manchester, Manchester, United Kingdom
N T McHugh School of Physics and Astronomy, University of Glasgow, Glasgow, United Kingdom
A McNab Department of Physics and Astronomy, University of Manchester, Manchester, United Kingdom
R McNulty School of Physics, University College Dublin, Dublin, Ireland
B Meadows University of Cincinnati, Cincinnati, Ohio, USA
G Meier Fakultät Physik, Technische Universität Dortmund, Dortmund, Germany
D Melnychuk National Center for Nuclear Research (NCBJ), Warsaw, Poland
M Merk Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands Universiteit Maastricht, Maastricht, Netherlands (associated with Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands)
A Merli INFN Sezione di Milano, Milano, Italy
L Meyer Garcia Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil
D Miao Institute Of High Energy Physics (IHEP), Beijing, China University of Chinese Academy of Sciences, Beijing, China
H Miao University of Chinese Academy of Sciences, Beijing, China
M Mikhasenko Universität Bonn - Helmholtz-Institut für Strahlen und Kernphysik, Bonn, Germany (associated with Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany)
D A Milanes Departamento de Fisica, Universidad Nacional de Colombia, Bogota, Colombia (associated with LPNHE, Sorbonne Université, Paris Diderot Sorbonne Paris Cité, CNRS/IN2P3, Paris, France)
A Minotti INFN Sezione di Milano-Bicocca, Milano, Italy
E Minucci Syracuse University, Syracuse, New York, USA
T Miralles Université Clermont Auvergne, CNRS/IN2P3, LPC, Clermont-Ferrand, France
S E Mitchell School of Physics and Astronomy, University of Edinburgh, Edinburgh, United Kingdom
B Mitreska Fakultät Physik, Technische Universität Dortmund, Dortmund, Germany
D S Mitzel Fakultät Physik, Technische Universität Dortmund, Dortmund, Germany
A Modak STFC Rutherford Appleton Laboratory, Didcot, United Kingdom
A Mödden Fakultät Physik, Technische Universität Dortmund, Dortmund, Germany
R A Mohammed Department of Physics, University of Oxford, Oxford, United Kingdom
R D Moise I. Physikalisches Institut, RWTH Aachen University, Aachen, Germany
S Mokhnenko Affiliated with an institute covered by a cooperation agreement with CERN
T Mombächer European Organization for Nuclear Research (CERN), Geneva, Switzerland
M Monk School of Physics and Astronomy, Monash University, Melbourne, Australia Department of Physics, University of Warwick, Coventry, United Kingdom
I A Monroy Departamento de Fisica, Universidad Nacional de Colombia, Bogota, Colombia (associated with LPNHE, Sorbonne Université, Paris Diderot Sorbonne Paris Cité, CNRS/IN2P3, Paris, France)
S Monteil Université Clermont Auvergne, CNRS/IN2P3, LPC, Clermont-Ferrand, France
A Morcillo Gomez Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
G Morello INFN Laboratori Nazionali di Frascati, Frascati, Italy
M J Morello INFN Sezione di Pisa, Pisa, Italy
M P Morgenthaler Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
J Moron AGH - University of Science and Technology, Faculty of Physics and Applied Computer Science, Kraków, Poland
A B Morris European Organization for Nuclear Research (CERN), Geneva, Switzerland
A G Morris Aix Marseille Univ, CNRS/IN2P3, CPPM, Marseille, France
R Mountain Syracuse University, Syracuse, New York, USA
H Mu Center for High Energy Physics, Tsinghua University, Beijing, China
Z M Mu School of Physics State Key Laboratory of Nuclear Physics and Technology, Peking University, Beijing, China
E Muhammad Department of Physics, University of Warwick, Coventry, United Kingdom
F Muheim School of Physics and Astronomy, University of Edinburgh, Edinburgh, United Kingdom
M Mulder Van Swinderen Institute, University of Groningen, Groningen, Netherlands (associated with Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands)
K Müller Physik-Institut, Universität Zürich, Zürich, Switzerland
F Mũnoz-Rojas Consejo Nacional de Rectores (CONARE), San Jose, Costa Rica
R Murta Imperial College London, London, United Kingdom
P Naik Oliver Lodge Laboratory, University of Liverpool, Liverpool, United Kingdom
T Nakada Institute of Physics, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland
R Nandakumar STFC Rutherford Appleton Laboratory, Didcot, United Kingdom
T Nanut European Organization for Nuclear Research (CERN), Geneva, Switzerland
I Nasteva Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil
M Needham School of Physics and Astronomy, University of Edinburgh, Edinburgh, United Kingdom
N Neri INFN Sezione di Milano, Milano, Italy
S Neubert Universität Bonn - Helmholtz-Institut für Strahlen und Kernphysik, Bonn, Germany (associated with Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany)
N Neufeld European Organization for Nuclear Research (CERN), Geneva, Switzerland
P Neustroev Affiliated with an institute covered by a cooperation agreement with CERN
R Newcombe Imperial College London, London, United Kingdom
J Nicolini Université Paris-Saclay, CNRS/IN2P3, IJCLab, Orsay, France Fakultät Physik, Technische Universität Dortmund, Dortmund, Germany
D Nicotra Universiteit Maastricht, Maastricht, Netherlands (associated with Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands)
E M Niel Institute of Physics, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland
N Nikitin Affiliated with an institute covered by a cooperation agreement with CERN
P Nogga Universität Bonn - Helmholtz-Institut für Strahlen und Kernphysik, Bonn, Germany (associated with Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany)
N S Nolte Massachusetts Institute of Technology, Cambridge, Massachusetts, USA
C Normand Université Savoie Mont Blanc, CNRS, IN2P3-LAPP, Annecy, France INFN Sezione di Cagliari, Monserrato, Italy
J Novoa Fernandez Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
G Nowak University of Cincinnati, Cincinnati, Ohio, USA
C Nunez University of Michigan, Ann Arbor, Michigan, USA (associated with Syracuse University, Syracuse, New York, USA)
H N Nur School of Physics and Astronomy, University of Glasgow, Glasgow, United Kingdom
A Oblakowska-Mucha AGH - University of Science and Technology, Faculty of Physics and Applied Computer Science, Kraków, Poland
V Obraztsov Affiliated with an institute covered by a cooperation agreement with CERN
T Oeser I. Physikalisches Institut, RWTH Aachen University, Aachen, Germany
S Okamura INFN Sezione di Ferrara, Ferrara, Italy European Organization for Nuclear Research (CERN), Geneva, Switzerland
R Oldeman INFN Sezione di Cagliari, Monserrato, Italy
F Oliva School of Physics and Astronomy, University of Edinburgh, Edinburgh, United Kingdom
M Olocco Fakultät Physik, Technische Universität Dortmund, Dortmund, Germany
C J G Onderwater Universiteit Maastricht, Maastricht, Netherlands (associated with Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands)
R H O'Neil School of Physics and Astronomy, University of Edinburgh, Edinburgh, United Kingdom
J M Otalora Goicochea Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil
T Ovsiannikova Affiliated with an institute covered by a cooperation agreement with CERN
P Owen Physik-Institut, Universität Zürich, Zürich, Switzerland
A Oyanguren Instituto de Fisica Corpuscular, Centro Mixto Universidad de Valencia - CSIC, Valencia, Spain
O Ozcelik School of Physics and Astronomy, University of Edinburgh, Edinburgh, United Kingdom
K O Padeken Universität Bonn - Helmholtz-Institut für Strahlen und Kernphysik, Bonn, Germany (associated with Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany)
B Pagare Department of Physics, University of Warwick, Coventry, United Kingdom
P R Pais Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
T Pajero Department of Physics, University of Oxford, Oxford, United Kingdom
A Palano INFN Sezione di Bari, Bari, Italy
M Palutan INFN Laboratori Nazionali di Frascati, Frascati, Italy
G Panshin Affiliated with an institute covered by a cooperation agreement with CERN
L Paolucci Department of Physics, University of Warwick, Coventry, United Kingdom
A Papanestis STFC Rutherford Appleton Laboratory, Didcot, United Kingdom
M Pappagallo INFN Sezione di Bari, Bari, Italy
L L Pappalardo INFN Sezione di Ferrara, Ferrara, Italy
C Pappenheimer University of Cincinnati, Cincinnati, Ohio, USA
C Parkes Department of Physics and Astronomy, University of Manchester, Manchester, United Kingdom
B Passalacqua INFN Sezione di Ferrara, Ferrara, Italy
G Passaleva INFN Sezione di Firenze, Firenze, Italy
D Passaro INFN Sezione di Pisa, Pisa, Italy
A Pastore INFN Sezione di Bari, Bari, Italy
M Patel Imperial College London, London, United Kingdom
J Patoc Department of Physics, University of Oxford, Oxford, United Kingdom
C Patrignani INFN Sezione di Bologna, Bologna, Italy
C J Pawley Universiteit Maastricht, Maastricht, Netherlands (associated with Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands)
A Pellegrino Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands
M Pepe Altarelli INFN Laboratori Nazionali di Frascati, Frascati, Italy
S Perazzini INFN Sezione di Bologna, Bologna, Italy
D Pereima Affiliated with an institute covered by a cooperation agreement with CERN
A Pereiro Castro Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
P Perret Université Clermont Auvergne, CNRS/IN2P3, LPC, Clermont-Ferrand, France
A Perro European Organization for Nuclear Research (CERN), Geneva, Switzerland
K Petridis H.H. Wills Physics Laboratory, University of Bristol, Bristol, United Kingdom
A Petrolini INFN Sezione di Genova, Genova, Italy
S Petrucci School of Physics and Astronomy, University of Edinburgh, Edinburgh, United Kingdom
H Pham Syracuse University, Syracuse, New York, USA
L Pica INFN Sezione di Pisa, Pisa, Italy
M Piccini INFN Sezione di Perugia, Perugia, Italy
B Pietrzyk Université Savoie Mont Blanc, CNRS, IN2P3-LAPP, Annecy, France
G Pietrzyk Université Paris-Saclay, CNRS/IN2P3, IJCLab, Orsay, France
D Pinci INFN Sezione di Roma La Sapienza, Roma, Italy
F Pisani European Organization for Nuclear Research (CERN), Geneva, Switzerland
M Pizzichemi INFN Sezione di Milano-Bicocca, Milano, Italy
V Placinta Horia Hulubei National Institute of Physics and Nuclear Engineering, Bucharest-Magurele, Romania
M Plo Casasus Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
F Polci LPNHE, Sorbonne Université, Paris Diderot Sorbonne Paris Cité, CNRS/IN2P3, Paris, France European Organization for Nuclear Research (CERN), Geneva, Switzerland
M Poli Lener INFN Laboratori Nazionali di Frascati, Frascati, Italy
A Poluektov Aix Marseille Univ, CNRS/IN2P3, CPPM, Marseille, France
N Polukhina Affiliated with an institute covered by a cooperation agreement with CERN
I Polyakov European Organization for Nuclear Research (CERN), Geneva, Switzerland
E Polycarpo Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil
S Ponce European Organization for Nuclear Research (CERN), Geneva, Switzerland
D Popov University of Chinese Academy of Sciences, Beijing, China
S Poslavskii Affiliated with an institute covered by a cooperation agreement with CERN
K Prasanth Henryk Niewodniczanski Institute of Nuclear Physics Polish Academy of Sciences, Kraków, Poland
C Prouve Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
V Pugatch Institute for Nuclear Research of the National Academy of Sciences (KINR), Kyiv, Ukraine
V Puill Université Paris-Saclay, CNRS/IN2P3, IJCLab, Orsay, France
G Punzi INFN Sezione di Pisa, Pisa, Italy
H R Qi Center for High Energy Physics, Tsinghua University, Beijing, China
W Qian University of Chinese Academy of Sciences, Beijing, China
N Qin Center for High Energy Physics, Tsinghua University, Beijing, China
S Qu Center for High Energy Physics, Tsinghua University, Beijing, China
R Quagliani Institute of Physics, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland
R I Rabadan Trejo Department of Physics, University of Warwick, Coventry, United Kingdom
B Rachwal AGH - University of Science and Technology, Faculty of Physics and Applied Computer Science, Kraków, Poland
J H Rademacker H.H. Wills Physics Laboratory, University of Bristol, Bristol, United Kingdom
M Rama INFN Sezione di Pisa, Pisa, Italy
M Ramírez García University of Michigan, Ann Arbor, Michigan, USA (associated with Syracuse University, Syracuse, New York, USA)
M Ramos Pernas Department of Physics, University of Warwick, Coventry, United Kingdom
M S Rangel Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil
F Ratnikov Affiliated with an institute covered by a cooperation agreement with CERN
G Raven Nikhef National Institute for Subatomic Physics and VU University Amsterdam, Amsterdam, Netherlands
M Rebollo De Miguel Instituto de Fisica Corpuscular, Centro Mixto Universidad de Valencia - CSIC, Valencia, Spain
F Redi European Organization for Nuclear Research (CERN), Geneva, Switzerland
J Reich H.H. Wills Physics Laboratory, University of Bristol, Bristol, United Kingdom
F Reiss Department of Physics and Astronomy, University of Manchester, Manchester, United Kingdom
Z Ren University of Chinese Academy of Sciences, Beijing, China
P K Resmi Department of Physics, University of Oxford, Oxford, United Kingdom
R Ribatti INFN Sezione di Pisa, Pisa, Italy
G R Ricart Laboratoire Leprince-Ringuet, CNRS/IN2P3, Ecole Polytechnique, Institut Polytechnique de Paris, Palaiseau, France Departement de Physique Nucleaire (SPhN), Gif-Sur-Yvette, France
D Riccardi INFN Sezione di Pisa, Pisa, Italy
S Ricciardi STFC Rutherford Appleton Laboratory, Didcot, United Kingdom
K Richardson Massachusetts Institute of Technology, Cambridge, Massachusetts, USA
M Richardson-Slipper School of Physics and Astronomy, University of Edinburgh, Edinburgh, United Kingdom
K Rinnert Oliver Lodge Laboratory, University of Liverpool, Liverpool, United Kingdom
P Robbe Université Paris-Saclay, CNRS/IN2P3, IJCLab, Orsay, France
G Robertson School of Physics and Astronomy, University of Glasgow, Glasgow, United Kingdom
E Rodrigues European Organization for Nuclear Research (CERN), Geneva, Switzerland Oliver Lodge Laboratory, University of Liverpool, Liverpool, United Kingdom
E Rodriguez Fernandez Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
J A Rodriguez Lopez Departamento de Fisica, Universidad Nacional de Colombia, Bogota, Colombia (associated with LPNHE, Sorbonne Université, Paris Diderot Sorbonne Paris Cité, CNRS/IN2P3, Paris, France)
E Rodriguez Rodriguez Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
A Rogovskiy STFC Rutherford Appleton Laboratory, Didcot, United Kingdom
D L Rolf European Organization for Nuclear Research (CERN), Geneva, Switzerland
A Rollings Department of Physics, University of Oxford, Oxford, United Kingdom
P Roloff European Organization for Nuclear Research (CERN), Geneva, Switzerland
V Romanovskiy Affiliated with an institute covered by a cooperation agreement with CERN
M Romero Lamas Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
A Romero Vidal Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
G Romolini INFN Sezione di Ferrara, Ferrara, Italy
F Ronchetti Institute of Physics, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland
M Rotondo INFN Laboratori Nazionali di Frascati, Frascati, Italy
S R Roy Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
M S Rudolph Syracuse University, Syracuse, New York, USA
T Ruf European Organization for Nuclear Research (CERN), Geneva, Switzerland
M Ruiz Diaz Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
R A Ruiz Fernandez Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
J Ruiz Vidal Department of Physics and Astronomy, Uppsala University, Uppsala, Sweden (associated with School of Physics and Astronomy, University of Glasgow, Glasgow, United Kingdom)
A Ryzhikov Affiliated with an institute covered by a cooperation agreement with CERN
J Ryzka AGH - University of Science and Technology, Faculty of Physics and Applied Computer Science, Kraków, Poland
J J Saborido Silva Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
R Sadek Laboratoire Leprince-Ringuet, CNRS/IN2P3, Ecole Polytechnique, Institut Polytechnique de Paris, Palaiseau, France
N Sagidova Affiliated with an institute covered by a cooperation agreement with CERN
N Sahoo University of Birmingham, Birmingham, United Kingdom
B Saitta INFN Sezione di Cagliari, Monserrato, Italy
M Salomoni INFN Sezione di Milano-Bicocca, Milano, Italy
C Sanchez Gras Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands
I Sanderswood Instituto de Fisica Corpuscular, Centro Mixto Universidad de Valencia - CSIC, Valencia, Spain
R Santacesaria INFN Sezione di Roma La Sapienza, Roma, Italy
C Santamarina Rios Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
M Santimaria INFN Laboratori Nazionali di Frascati, Frascati, Italy
L Santoro Centro Brasileiro de Pesquisas Físicas (CBPF), Rio de Janeiro, Brazil
E Santovetti INFN Sezione di Roma Tor Vergata, Roma, Italy
A Saputi INFN Sezione di Ferrara, Ferrara, Italy European Organization for Nuclear Research (CERN), Geneva, Switzerland
D Saranin Affiliated with an institute covered by a cooperation agreement with CERN
G Sarpis School of Physics and Astronomy, University of Edinburgh, Edinburgh, United Kingdom
M Sarpis Universität Bonn - Helmholtz-Institut für Strahlen und Kernphysik, Bonn, Germany (associated with Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany)
A Sarti INFN Sezione di Roma La Sapienza, Roma, Italy
C Satriano INFN Sezione di Roma La Sapienza, Roma, Italy
A Satta INFN Sezione di Roma Tor Vergata, Roma, Italy
M Saur School of Physics State Key Laboratory of Nuclear Physics and Technology, Peking University, Beijing, China
D Savrina Affiliated with an institute covered by a cooperation agreement with CERN
H Sazak Université Clermont Auvergne, CNRS/IN2P3, LPC, Clermont-Ferrand, France
L G Scantlebury Smead Department of Physics, University of Oxford, Oxford, United Kingdom
A Scarabotto LPNHE, Sorbonne Université, Paris Diderot Sorbonne Paris Cité, CNRS/IN2P3, Paris, France
S Schael I. Physikalisches Institut, RWTH Aachen University, Aachen, Germany
S Scherl Oliver Lodge Laboratory, University of Liverpool, Liverpool, United Kingdom
A M Schertz Eotvos Lorand University, Budapest, Hungary (associated with European Organization for Nuclear Research (CERN), Geneva, Switzerland)
M Schiller School of Physics and Astronomy, University of Glasgow, Glasgow, United Kingdom
H Schindler European Organization for Nuclear Research (CERN), Geneva, Switzerland
M Schmelling Max-Planck-Institut für Kernphysik (MPIK), Heidelberg, Germany
B Schmidt European Organization for Nuclear Research (CERN), Geneva, Switzerland
S Schmitt I. Physikalisches Institut, RWTH Aachen University, Aachen, Germany
H Schmitz Universität Bonn - Helmholtz-Institut für Strahlen und Kernphysik, Bonn, Germany (associated with Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany)
O Schneider Institute of Physics, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland
A Schopper European Organization for Nuclear Research (CERN), Geneva, Switzerland
N Schulte Fakultät Physik, Technische Universität Dortmund, Dortmund, Germany
S Schulte Institute of Physics, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland
M H Schune Université Paris-Saclay, CNRS/IN2P3, IJCLab, Orsay, France
R Schwemmer European Organization for Nuclear Research (CERN), Geneva, Switzerland
G Schwering I. Physikalisches Institut, RWTH Aachen University, Aachen, Germany
B Sciascia INFN Laboratori Nazionali di Frascati, Frascati, Italy
A Sciuccati European Organization for Nuclear Research (CERN), Geneva, Switzerland
S Sellam Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
A Semennikov Affiliated with an institute covered by a cooperation agreement with CERN
M Senghi Soares Nikhef National Institute for Subatomic Physics and VU University Amsterdam, Amsterdam, Netherlands
A Sergi INFN Sezione di Genova, Genova, Italy
N Serra European Organization for Nuclear Research (CERN), Geneva, Switzerland Physik-Institut, Universität Zürich, Zürich, Switzerland
L Sestini Università degli Studi di Padova, Università e INFN, Padova, Padova, Italy
A Seuthe Fakultät Physik, Technische Universität Dortmund, Dortmund, Germany
Y Shang School of Physics State Key Laboratory of Nuclear Physics and Technology, Peking University, Beijing, China
D M Shangase University of Michigan, Ann Arbor, Michigan, USA (associated with Syracuse University, Syracuse, New York, USA)
M Shapkin Affiliated with an institute covered by a cooperation agreement with CERN
I Shchemerov Affiliated with an institute covered by a cooperation agreement with CERN
L Shchutska Institute of Physics, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland
T Shears Oliver Lodge Laboratory, University of Liverpool, Liverpool, United Kingdom
L Shekhtman Affiliated with an institute covered by a cooperation agreement with CERN
Z Shen School of Physics State Key Laboratory of Nuclear Physics and Technology, Peking University, Beijing, China
S Sheng Institute Of High Energy Physics (IHEP), Beijing, China University of Chinese Academy of Sciences, Beijing, China
V Shevchenko Affiliated with an institute covered by a cooperation agreement with CERN
B Shi University of Chinese Academy of Sciences, Beijing, China
E B Shields INFN Sezione di Milano-Bicocca, Milano, Italy
Y Shimizu Université Paris-Saclay, CNRS/IN2P3, IJCLab, Orsay, France
E Shmanin Affiliated with an institute covered by a cooperation agreement with CERN
R Shorkin Affiliated with an institute covered by a cooperation agreement with CERN
J D Shupperd Syracuse University, Syracuse, New York, USA
R Silva Coutinho Syracuse University, Syracuse, New York, USA
G Simi Università degli Studi di Padova, Università e INFN, Padova, Padova, Italy
S Simone INFN Sezione di Bari, Bari, Italy
N Skidmore Department of Physics and Astronomy, University of Manchester, Manchester, United Kingdom
R Skuza Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
T Skwarnicki Syracuse University, Syracuse, New York, USA
M W Slater University of Birmingham, Birmingham, United Kingdom
J C Smallwood Department of Physics, University of Oxford, Oxford, United Kingdom
E Smith Massachusetts Institute of Technology, Cambridge, Massachusetts, USA
K Smith Los Alamos National Laboratory (LANL), Los Alamos, New Mexico, USA
M Smith Imperial College London, London, United Kingdom
A Snoch Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands
L Soares Lavra School of Physics and Astronomy, University of Edinburgh, Edinburgh, United Kingdom
M D Sokoloff University of Cincinnati, Cincinnati, Ohio, USA
F J P Soler School of Physics and Astronomy, University of Glasgow, Glasgow, United Kingdom
A Solomin Affiliated with an institute covered by a cooperation agreement with CERN H.H. Wills Physics Laboratory, University of Bristol, Bristol, United Kingdom
A Solovev Affiliated with an institute covered by a cooperation agreement with CERN
I Solovyev Affiliated with an institute covered by a cooperation agreement with CERN
R Song School of Physics and Astronomy, Monash University, Melbourne, Australia
Y Song Institute of Physics, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland
Y Song Center for High Energy Physics, Tsinghua University, Beijing, China
Y S Song School of Physics State Key Laboratory of Nuclear Physics and Technology, Peking University, Beijing, China
F L Souza De Almeida Syracuse University, Syracuse, New York, USA
B Souza De Paula Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil
E Spadaro Norella INFN Sezione di Milano, Milano, Italy
E Spedicato INFN Sezione di Bologna, Bologna, Italy
J G Speer Fakultät Physik, Technische Universität Dortmund, Dortmund, Germany
E Spiridenkov Affiliated with an institute covered by a cooperation agreement with CERN
P Spradlin School of Physics and Astronomy, University of Glasgow, Glasgow, United Kingdom
V Sriskaran European Organization for Nuclear Research (CERN), Geneva, Switzerland
F Stagni European Organization for Nuclear Research (CERN), Geneva, Switzerland
M Stahl European Organization for Nuclear Research (CERN), Geneva, Switzerland
S Stahl European Organization for Nuclear Research (CERN), Geneva, Switzerland
S Stanislaus Department of Physics, University of Oxford, Oxford, United Kingdom
E N Stein European Organization for Nuclear Research (CERN), Geneva, Switzerland
O Steinkamp Physik-Institut, Universität Zürich, Zürich, Switzerland
O Stenyakin Affiliated with an institute covered by a cooperation agreement with CERN
H Stevens Fakultät Physik, Technische Universität Dortmund, Dortmund, Germany
D Strekalina Affiliated with an institute covered by a cooperation agreement with CERN
Y Su University of Chinese Academy of Sciences, Beijing, China
F Suljik Department of Physics, University of Oxford, Oxford, United Kingdom
J Sun INFN Sezione di Cagliari, Monserrato, Italy
L Sun School of Physics and Technology, Wuhan University, Wuhan, China (associated with Center for High Energy Physics, Tsinghua University, Beijing, China)
Y Sun University of Maryland, College Park, Maryland, USA
P N Swallow University of Birmingham, Birmingham, United Kingdom
K Swientek AGH - University of Science and Technology, Faculty of Physics and Applied Computer Science, Kraków, Poland
F Swystun Department of Physics, University of Warwick, Coventry, United Kingdom
A Szabelski National Center for Nuclear Research (NCBJ), Warsaw, Poland
T Szumlak AGH - University of Science and Technology, Faculty of Physics and Applied Computer Science, Kraków, Poland
M Szymanski European Organization for Nuclear Research (CERN), Geneva, Switzerland
Y Tan Center for High Energy Physics, Tsinghua University, Beijing, China
S Taneja Department of Physics and Astronomy, University of Manchester, Manchester, United Kingdom
M D Tat Department of Physics, University of Oxford, Oxford, United Kingdom
A Terentev Physik-Institut, Universität Zürich, Zürich, Switzerland
F Terzuoli INFN Sezione di Pisa, Pisa, Italy
F Teubert European Organization for Nuclear Research (CERN), Geneva, Switzerland
E Thomas European Organization for Nuclear Research (CERN), Geneva, Switzerland
D J D Thompson University of Birmingham, Birmingham, United Kingdom
H Tilquin Imperial College London, London, United Kingdom
V Tisserand Université Clermont Auvergne, CNRS/IN2P3, LPC, Clermont-Ferrand, France
S T'Jampens Université Savoie Mont Blanc, CNRS, IN2P3-LAPP, Annecy, France
M Tobin Institute Of High Energy Physics (IHEP), Beijing, China
L Tomassetti INFN Sezione di Ferrara, Ferrara, Italy
G Tonani INFN Sezione di Milano, Milano, Italy
X Tong School of Physics State Key Laboratory of Nuclear Physics and Technology, Peking University, Beijing, China
D Torres Machado Centro Brasileiro de Pesquisas Físicas (CBPF), Rio de Janeiro, Brazil
L Toscano Fakultät Physik, Technische Universität Dortmund, Dortmund, Germany
D Y Tou Center for High Energy Physics, Tsinghua University, Beijing, China
C Trippl DS4DS, La Salle, Universitat Ramon Llull, Barcelona, Spain
G Tuci Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
N Tuning Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands
L H Uecker Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
A Ukleja AGH - University of Science and Technology, Faculty of Physics and Applied Computer Science, Kraków, Poland
D J Unverzagt Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
E Ursov Affiliated with an institute covered by a cooperation agreement with CERN
A Usachov Nikhef National Institute for Subatomic Physics and VU University Amsterdam, Amsterdam, Netherlands
A Ustyuzhanin Affiliated with an institute covered by a cooperation agreement with CERN
U Uwer Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
V Vagnoni INFN Sezione di Bologna, Bologna, Italy
A Valassi European Organization for Nuclear Research (CERN), Geneva, Switzerland
G Valenti INFN Sezione di Bologna, Bologna, Italy
N Valls Canudas DS4DS, La Salle, Universitat Ramon Llull, Barcelona, Spain
H Van Hecke Los Alamos National Laboratory (LANL), Los Alamos, New Mexico, USA
E van Herwijnen Imperial College London, London, United Kingdom
C B Van Hulse Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
R Van Laak Institute of Physics, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland
M van Veghel Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands
R Vazquez Gomez ICCUB, Universitat de Barcelona, Barcelona, Spain
P Vazquez Regueiro Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
C Vázquez Sierra Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
S Vecchi INFN Sezione di Ferrara, Ferrara, Italy
J J Velthuis H.H. Wills Physics Laboratory, University of Bristol, Bristol, United Kingdom
M Veltri INFN Sezione di Firenze, Firenze, Italy
A Venkateswaran Institute of Physics, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland
M Vesterinen Department of Physics, University of Warwick, Coventry, United Kingdom
D Vieira University of Cincinnati, Cincinnati, Ohio, USA
M Vieites Diaz European Organization for Nuclear Research (CERN), Geneva, Switzerland
X Vilasis-Cardona DS4DS, La Salle, Universitat Ramon Llull, Barcelona, Spain
E Vilella Figueras Oliver Lodge Laboratory, University of Liverpool, Liverpool, United Kingdom
A Villa INFN Sezione di Bologna, Bologna, Italy
P Vincent LPNHE, Sorbonne Université, Paris Diderot Sorbonne Paris Cité, CNRS/IN2P3, Paris, France
F C Volle Université Paris-Saclay, CNRS/IN2P3, IJCLab, Orsay, France
D Vom Bruch Aix Marseille Univ, CNRS/IN2P3, CPPM, Marseille, France
V Vorobyev Affiliated with an institute covered by a cooperation agreement with CERN
N Voropaev Affiliated with an institute covered by a cooperation agreement with CERN
K Vos Universiteit Maastricht, Maastricht, Netherlands (associated with Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands)
G Vouters Université Savoie Mont Blanc, CNRS, IN2P3-LAPP, Annecy, France
C Vrahas School of Physics and Astronomy, University of Edinburgh, Edinburgh, United Kingdom
J Walsh INFN Sezione di Pisa, Pisa, Italy
E J Walton School of Physics and Astronomy, Monash University, Melbourne, Australia
G Wan School of Physics State Key Laboratory of Nuclear Physics and Technology, Peking University, Beijing, China
C Wang Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
G Wang Institute of Particle Physics, Central China Normal University, Wuhan, Hubei, China
J Wang School of Physics State Key Laboratory of Nuclear Physics and Technology, Peking University, Beijing, China
J Wang Institute Of High Energy Physics (IHEP), Beijing, China
J Wang Center for High Energy Physics, Tsinghua University, Beijing, China
J Wang School of Physics and Technology, Wuhan University, Wuhan, China (associated with Center for High Energy Physics, Tsinghua University, Beijing, China)
M Wang INFN Sezione di Milano, Milano, Italy
N W Wang University of Chinese Academy of Sciences, Beijing, China
R Wang H.H. Wills Physics Laboratory, University of Bristol, Bristol, United Kingdom
X Wang Guangdong Provincial Key Laboratory of Nuclear Science, Guangdong-Hong Kong Joint Laboratory of Quantum Matter, Institute of Quantum Matter, South China Normal University, Guangzhou, China (associated with Center for High Energy Physics, Tsinghua University, Beijing, China)
X W Wang Imperial College London, London, United Kingdom
Y Wang Institute of Particle Physics, Central China Normal University, Wuhan, Hubei, China
Z Wang Université Paris-Saclay, CNRS/IN2P3, IJCLab, Orsay, France
Z Wang Center for High Energy Physics, Tsinghua University, Beijing, China
Z Wang University of Chinese Academy of Sciences, Beijing, China
J A Ward School of Physics and Astronomy, Monash University, Melbourne, Australia Department of Physics, University of Warwick, Coventry, United Kingdom
N K Watson University of Birmingham, Birmingham, United Kingdom
D Websdale Imperial College London, London, United Kingdom
Y Wei School of Physics State Key Laboratory of Nuclear Physics and Technology, Peking University, Beijing, China
B D C Westhenry H.H. Wills Physics Laboratory, University of Bristol, Bristol, United Kingdom
D J White Department of Physics and Astronomy, University of Manchester, Manchester, United Kingdom
M Whitehead School of Physics and Astronomy, University of Glasgow, Glasgow, United Kingdom
A R Wiederhold Department of Physics, University of Warwick, Coventry, United Kingdom
D Wiedner Fakultät Physik, Technische Universität Dortmund, Dortmund, Germany
G Wilkinson Department of Physics, University of Oxford, Oxford, United Kingdom
M K Wilkinson University of Cincinnati, Cincinnati, Ohio, USA
M Williams Massachusetts Institute of Technology, Cambridge, Massachusetts, USA
M R J Williams School of Physics and Astronomy, University of Edinburgh, Edinburgh, United Kingdom
R Williams Cavendish Laboratory, University of Cambridge, Cambridge, United Kingdom
F F Wilson STFC Rutherford Appleton Laboratory, Didcot, United Kingdom
W Wislicki National Center for Nuclear Research (NCBJ), Warsaw, Poland
M Witek Henryk Niewodniczanski Institute of Nuclear Physics Polish Academy of Sciences, Kraków, Poland
L Witola Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
C P Wong Los Alamos National Laboratory (LANL), Los Alamos, New Mexico, USA
G Wormser Université Paris-Saclay, CNRS/IN2P3, IJCLab, Orsay, France
S A Wotton Cavendish Laboratory, University of Cambridge, Cambridge, United Kingdom
H Wu Syracuse University, Syracuse, New York, USA
J Wu Institute of Particle Physics, Central China Normal University, Wuhan, Hubei, China
Y Wu School of Physics State Key Laboratory of Nuclear Physics and Technology, Peking University, Beijing, China
K Wyllie European Organization for Nuclear Research (CERN), Geneva, Switzerland
S Xian Guangdong Provincial Key Laboratory of Nuclear Science, Guangdong-Hong Kong Joint Laboratory of Quantum Matter, Institute of Quantum Matter, South China Normal University, Guangzhou, China (associated with Center for High Energy Physics, Tsinghua University, Beijing, China)
Z Xiang Institute Of High Energy Physics (IHEP), Beijing, China
Y Xie Institute of Particle Physics, Central China Normal University, Wuhan, Hubei, China
A Xu INFN Sezione di Pisa, Pisa, Italy
J Xu University of Chinese Academy of Sciences, Beijing, China
L Xu Center for High Energy Physics, Tsinghua University, Beijing, China
L Xu Center for High Energy Physics, Tsinghua University, Beijing, China
M Xu Department of Physics, University of Warwick, Coventry, United Kingdom
Z Xu Université Clermont Auvergne, CNRS/IN2P3, LPC, Clermont-Ferrand, France
Z Xu University of Chinese Academy of Sciences, Beijing, China
Z Xu Institute Of High Energy Physics (IHEP), Beijing, China
D Yang Center for High Energy Physics, Tsinghua University, Beijing, China
S Yang University of Chinese Academy of Sciences, Beijing, China
X Yang School of Physics State Key Laboratory of Nuclear Physics and Technology, Peking University, Beijing, China
Y Yang INFN Sezione di Genova, Genova, Italy
Z Yang School of Physics State Key Laboratory of Nuclear Physics and Technology, Peking University, Beijing, China
Z Yang University of Maryland, College Park, Maryland, USA
V Yeroshenko Université Paris-Saclay, CNRS/IN2P3, IJCLab, Orsay, France
H Yeung Department of Physics and Astronomy, University of Manchester, Manchester, United Kingdom
H Yin Institute of Particle Physics, Central China Normal University, Wuhan, Hubei, China
C Y Yu School of Physics State Key Laboratory of Nuclear Physics and Technology, Peking University, Beijing, China
J Yu School of Physics and Electronics, Hunan University, Changsha City, China (associated with Institute of Particle Physics, Central China Normal University, Wuhan, Hubei, China)
X Yuan Institute Of High Energy Physics (IHEP), Beijing, China
E Zaffaroni Institute of Physics, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland
M Zavertyaev Max-Planck-Institut für Kernphysik (MPIK), Heidelberg, Germany
M Zdybal Henryk Niewodniczanski Institute of Nuclear Physics Polish Academy of Sciences, Kraków, Poland
M Zeng Center for High Energy Physics, Tsinghua University, Beijing, China
C Zhang School of Physics State Key Laboratory of Nuclear Physics and Technology, Peking University, Beijing, China
D Zhang Institute of Particle Physics, Central China Normal University, Wuhan, Hubei, China
J Zhang University of Chinese Academy of Sciences, Beijing, China
L Zhang Center for High Energy Physics, Tsinghua University, Beijing, China
S Zhang School of Physics and Electronics, Hunan University, Changsha City, China (associated with Institute of Particle Physics, Central China Normal University, Wuhan, Hubei, China)
S Zhang School of Physics State Key Laboratory of Nuclear Physics and Technology, Peking University, Beijing, China
Y Zhang School of Physics State Key Laboratory of Nuclear Physics and Technology, Peking University, Beijing, China
Y Zhang Department of Physics, University of Oxford, Oxford, United Kingdom
Y Z Zhang Center for High Energy Physics, Tsinghua University, Beijing, China
Y Zhao Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
A Zharkova Affiliated with an institute covered by a cooperation agreement with CERN
A Zhelezov Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
X Z Zheng Center for High Energy Physics, Tsinghua University, Beijing, China
Y Zheng University of Chinese Academy of Sciences, Beijing, China
T Zhou School of Physics State Key Laboratory of Nuclear Physics and Technology, Peking University, Beijing, China
X Zhou Institute of Particle Physics, Central China Normal University, Wuhan, Hubei, China
Y Zhou University of Chinese Academy of Sciences, Beijing, China
V Zhovkovska Department of Physics, University of Warwick, Coventry, United Kingdom
L Z Zhu University of Chinese Academy of Sciences, Beijing, China
X Zhu Center for High Energy Physics, Tsinghua University, Beijing, China
X Zhu Institute of Particle Physics, Central China Normal University, Wuhan, Hubei, China
Z Zhu University of Chinese Academy of Sciences, Beijing, China
V Zhukov I. Physikalisches Institut, RWTH Aachen University, Aachen, Germany Affiliated with an institute covered by a cooperation agreement with CERN
J Zhuo Instituto de Fisica Corpuscular, Centro Mixto Universidad de Valencia - CSIC, Valencia, Spain
Q Zou Institute Of High Energy Physics (IHEP), Beijing, China University of Chinese Academy of Sciences, Beijing, China
D Zuliani Università degli Studi di Padova, Università e INFN, Padova, Padova, Italy
G Zunica Department of Physics and Astronomy, University of Manchester, Manchester, United Kingdom

Collapse

Incidence and predictors of intraoperative hypotension during transurethral bladder tumor resection with oral 5-aminolevulinic acid

OBJECTIVES

To analyze the incidence and risk factors of intraoperative hypotension related to photodynamic diagnosis-assisted transurethral resection of bladder tumor (PDD-TURBT) with oral 5-aminolevulinic acid (5-ALA).

METHODS

We retrospectively analyzed 487 patients with bladder tumors who underwent PDD-TURBT (n = 184) or conventional TURBT (conv-TURBT) (n = 303) between 2018 and 2021. Intraoperative hypotension was defined as hypotension requiring vasopressors during TURBT, and its incidence was compared between the two groups. Potential risk factors of intraoperative hypotension, including preoperative change in mean arterial pressure (MAP), were further investigated in patients receiving PDD-TURBT.

RESULTS

The median age was 72 years, 392 patients (81%) were male, and 203 (42%) had hypertension. TURBT was performed under general and spinal anesthesia in 76 (16%) and 411 (84%) patients, respectively. The incidence of intraoperative hypotension was significantly higher in PDD-TURBT compared to conv-TURBT (43% vs. 17%, respectively). The median change in MAP until the induction of anesthesia was +6.5 mmHg (range: -29.0 to +46.3) in the PDD-TURBT group and +14.7 mmHg (range: -35.3 to +67.7) in the conv-TURBT group, showing a significantly smaller increase in the PDD-TURBT group (p < 0.001). In the multivariable analysis for PDD-TURBT patients, advanced age, general anesthesia, and lower MAP change (<+6.5 mmHg) until anesthesia induction were significantly associated with intraoperative hypotension (p = 0.0104, <0.001, and <0.001, respectively).

CONCLUSIONS

Intraoperative hypotension occurred more frequently in patients who underwent PDD-TURBT than in those who underwent conv-TURBT. Using oral 5-ALA decreases preoperative blood pressure elevation and may be responsible for intraoperative hypotension.

Summary of the Clinical Practice Guidelines for Upper Tract Urothelial Carcinoma 2023 by the Japanese Urological Association

This article is an English translation of the Clinical Practice Guidelines for Upper Tract Urothelial Carcinoma (2nd edition) published in June 2023. The Japanese Urological Association's (JUA) Guidelines Committee on Upper Tract Urothelial Carcinoma (UTUC) created a 2023 update guideline to support clinicians' current evidence-based management of UTUC and to incorporate its recommendations into clinical practice. The new guideline adhered as closely as possible to the Minds Manual for Guideline Development 2020 ver. 3.0. Findings related to epidemiological, pathological, diagnosis, treatment, and follow-up were reviewed. In addition, seven clinical questions (CQs) were set to determine the grade of recommendation and level of evidence. Preconceptions and biases were removed from the preparation process, the overall evidence was evaluated appropriately, and recommendations were made after fully considering the balance between benefits and harms. Although the evidence is still insufficient to be taken up as a CQ, the latest important information is described in seven columns, and clinical issues that should be resolved in the future related to the CQ are described as recommendations for tomorrow. We hope that these guidelines will help medical professionals, patients, and their families involved in the treatment of UTUC in their decision-making, and hope that a critical review of these guidelines will lead to further refinements in the next edition.

Observation of Cabibbo-Suppressed Two-Body Hadronic Decays and Precision Mass Measurement of the Ω_{c}^{0} Baryon

The first observation of the singly Cabibbo-suppressed Ω_{c}^{0}→Ω^{-}K^{+} and Ω_{c}^{0}→Ξ^{-}π^{+} decays is reported, using proton-proton collision data at a center-of-mass energy of 13 TeV, corresponding to an integrated luminosity of 5.4  fb^{-1}, collected with the LHCb detector between 2016 and 2018. The branching fraction ratios are measured to be B(Ω_{c}^{0}→Ω^{-}K^{+})/B(Ω_{c}^{0}→Ω^{-}π^{+})=[6.08±0.51(stat)±0.40(syst)]%,B(Ω_{c}^{0}→Ξ^{-}π^{+})/B(Ω_{c}^{0}→Ω^{-}π^{+})=[15.81±0.87(stat)±0.44(syst)±0.16(ext)]%. In addition, using the Ω_{c}^{0}→Ω^{-}π^{+} decay channel, the Ω_{c}^{0} baryon mass is measured to be M(Ω_{c}^{0})=2695.28±0.07(stat)±0.27(syst)±0.30(ext)  MeV, improving the precision of the previous world average by a factor of 4.

Enhanced Production of Λ_{b}^{0} Baryons in High-Multiplicity pp Collisions at sqrt[s]=13 TeV

The production rate of Λ_{b}^{0} baryons relative to B^{0} mesons in pp collisions at a center-of-mass energy sqrt[s]=13  TeV is measured by the LHCb experiment. The ratio of Λ_{b}^{0} to B^{0} production cross sections shows a significant dependence on both the transverse momentum and the measured charged-particle multiplicity. At low multiplicity, the ratio measured at LHCb is consistent with the value measured in e^{+}e^{-} collisions, and increases by a factor of ∼2 with increasing multiplicity. At relatively low transverse momentum, the ratio of Λ_{b}^{0} to B^{0} cross sections is higher than what is measured in e^{+}e^{-} collisions, but converges with the e^{+}e^{-} ratio as the momentum increases. These results imply that the evolution of heavy b quarks into final-state hadrons is influenced by the density of the hadronic environment produced in the collision. Comparisons with several models and implications for the mechanisms enforcing quark confinement are discussed.

Improved Measurement of CP Violation Parameters in B_{s}^{0}→J/ψK^{+}K^{-} Decays in the Vicinity of the ϕ(1020) Resonance

The decay-time-dependent CP asymmetry in B_{s}^{0}→J/ψ(→μ^{+}μ^{-})K^{+}K^{-} decays is measured using proton-proton collision data, corresponding to an integrated luminosity of 6  fb^{-1}, collected with the LHCb detector at a center-of-mass energy of 13 TeV. Using a sample of approximately 349 000 B_{s}^{0} signal decays with an invariant K^{+}K^{-} mass in the vicinity of the ϕ(1020) resonance, the CP-violating phase ϕ_{s} is measured, along with the difference in decay widths of the light and heavy mass eigenstates of the B_{s}^{0}-B[over ¯]_{s}^{0} system, ΔΓ_{s}, and the difference of the average B_{s}^{0} and B^{0} meson decay widths, Γ_{s}-Γ_{d}. The values obtained are ϕ_{s}=-0.039±0.022±0.006  rad, ΔΓ_{s}=0.0845±0.0044±0.0024  ps^{-1}, and Γ_{s}-Γ_{d}=-0.0056_{-0.0015}^{+0.0013}±0.0014  ps^{-1}, where the first uncertainty is statistical and the second systematic. These are the most precise single measurements to date and are consistent with expectations based on the Standard Model and with the previous LHCb analyses of this decay. These results are combined with previous independent LHCb measurements. The phase ϕ_{s} is also measured independently for each polarization state of the K^{+}K^{-} system and shows no evidence for polarization dependence.

Incidence, risk factors, and significance of 20% decrease from new baseline estimated glomerular filtration rate after radical and partial nephrectomy within 2 years

OBJECTIVES

To evaluate the incidence and risk factors of a 20% decrease from new baseline (NB)-estimated glomerular filtration rate (eGFR) within 2 years after radical nephrectomy (RN) and partial nephrectomy (PN) and to examine the difference in the incidence of end-stage renal disease (ESRD) with or without the 20% decrease.

METHODS

This retrospective study included 238 patients undergoing RN and 369 undergoing PN for cT1a-cT3a renal cancer. The incidence of a 20% decrease from NB-eGFR within 2 years after RN/PN was examined and its potential risk factors including surgery type were assessed by multivariate logistic regression analysis. The development of ESRD was analyzed as an endpoint and its incidence was compared according to the presence or absence of the 20% decrease from NB-eGFR within 2 years.

RESULTS

Overall, the 20% decrease from NB-eGFR within 2 years was observed in 37 patients (6.1%), including 10 (4.2%) and 27 (7.3%) after RN and PN, respectively (p = 0.117). Diabetes mellitus, proteinuria, and perioperative complications were shown to be independent risk factors for the 20% decrease from NB-eGFR, while surgery type was not. During the median follow-up of 65 months, the ESRD-free survival rate at 6 years was 75.5% and 99.6% in patients with and without the 20% decrease from NB-eGFR, respectively (p < 0.001), while no significant difference was observed between patients undergoing RN and PN (98.1% and 98.7%, p = 0.561).

CONCLUSIONS

Because the incidence of ESRD after the 20% decrease from NB-eGFR within 2 years was as high as 24.5% at 6 years, these patients should be followed with utmost care.

Single-Nucleus Analysis Reveals Tumor Heterogeneity of Aldosterone-Producing Adenoma

BACKGROUND

Recent advances in omics techniques have allowed detailed genetic characterization of aldosterone-producing adenoma (APA). The pathogenesis of APA is characterized by tumorigenesis-associated aldosterone synthesis. The pathophysiological intricacies of APAs have not yet been elucidated at the level of individual cells. Therefore, a single-cell level analysis is speculated to be valuable in studying the differentiation process of APA.

METHODS

We conducted single-nucleus RNA sequencing of APAs with KCNJ5 mutation and nonfunctional adenomas obtained from 3 and 2 patients, respectively.

RESULTS

The single-nucleus RNA sequencing revealed the intratumoral heterogeneity of APA and identified cell populations consisting of a shared cluster of nonfunctional adenoma and APA. In addition, we extracted 2 cell fates in APA and obtained a cell population specialized in aldosterone synthesis. Genes related to ribosomes and neurodegenerative diseases were upregulated in 1 of these fates, whereas those related to the regulation of glycolysis were upregulated in the other fate. Furthermore, the total RNA reads in the nucleus were higher in hormonally activated clusters, indicating a marked activation of transcription per cell.

CONCLUSIONS

The single-nucleus RNA sequencing revealed intratumoral heterogeneity of APA with KCNJ5 mutation. The observation of 2 cell fates in KCNJ5-mutated APAs provides the postulation that a heterogeneous process of cellular differentiation was implicated in the pathophysiological mechanisms underlying APA tumors.

Measurement of CP Violation in B^{0}→ψ(→ℓ^{+}ℓ^{-})K_{S}^{0}(→π^{+}π^{-}) Decays

A measurement of time-dependent CP violation in the decays of B^{0} and B[over ¯]^{0} mesons to the final states J/ψ(→μ^{+}μ^{-})K_{S}^{0}, ψ(2S)(→μ^{+}μ^{-})K_{S}^{0} and J/ψ(→e^{+}e^{-})K_{S}^{0} with K_{S}^{0}→π^{+}π^{-} is presented. The data correspond to an integrated luminosity of 6  fb^{-1} collected at a center-of-mass energy of sqrt[s]=13  TeV with the LHCb detector. The CP-violation parameters are measured to be S_{ψK_{S}^{0}}=0.717±0.013(stat)±0.008(syst) and C_{ψK_{S}^{0}}=0.008±0.012(stat)±0.003(syst). This measurement of S_{ψK_{S}^{0}} represents the most precise single measurement of the CKM angle β to date and is more precise than the current world average. In addition, measurements of the CP-violation parameters of the individual channels are reported and a combination with the LHCb Run 1 measurements is performed.

Longitudinal deterioration in lower urinary tract symptoms after artificial urinary sphincter implantation in patients with a history of pelvic radiation therapy

OBJECTIVES

To evaluate longitudinal changes in lower urinary tract symptoms (LUTS) after artificial urinary sphincter (AUS) implantation in patients undergoing radiation therapy (RT) in comparison to those in non-irradiated patients.

METHODS

This retrospective study included 20 and 51 patients with and without a history of pelvic RT (RT and non-RT group, respectively) who were treated with primary AUS implantation for post-radical prostatectomy incontinence between 2010 and 2020. Longitudinal changes in the International Consultation on Incontinence Questionnaire-Short Form (ICIQ-SF), the International Prostate Symptom Score (IPSS), and the Overactive Bladder Symptom Score (OABSS) were calculated with a linear mixed model.

RESULTS

In the RT and non-RT group, 18 (90%) and 48 (94%) patients achieved social continence, defined as daily pad use ≤1 at 1 month after activation of AUS, respectively (p = .555). During the mean follow-up of 38 months, ICIQ-SF, IPSS, and OABSS significantly improved after AUS implantation in both the RT and non-RT groups. In the RT group, ICIQ-SF, IPSS, and OABSS subsequently deteriorated with a slope of 0.62/year (p = .010), 0.55/year (p = .025), and 0.30/year (p = .007), respectively. In the non-RT group, no significant longitudinal changes in subsequent IPSS and OABSS were observed, although ICIQ-SF significantly deteriorated (0.43/year, p = .006). Comparing between the groups, the slopes of IPSS and OABSS were significantly greater in the RT group than in the non-RT group (p < .001, and .015, respectively).

CONCLUSIONS

Longitudinal deterioration in LUTS that improved immediately after AUS implantation was observed in patients with a history of pelvic RT, but not in patients without a history of pelvic RT.

Deep-learning prostate cancer detection and segmentation on biparametric versus multiparametric magnetic resonance imaging: Added value of dynamic contrast-enhanced imaging

OBJECTIVES

To develop diagnostic algorithms of multisequence prostate magnetic resonance imaging for cancer detection and segmentation using deep learning and explore values of dynamic contrast-enhanced imaging in multiparametric imaging, compared with biparametric imaging.

METHODS

We collected 3227 multiparametric imaging sets from 332 patients, including 218 cancer patients (291 biopsy-proven foci) and 114 noncancer patients. Diagnostic algorithms of T2-weighted, T2-weighted plus dynamic contrast-enhanced, biparametric, and multiparametric imaging were built using 2578 sets, and their performance for clinically significant cancer was evaluated using 649 sets.

RESULTS

Biparametric and multiparametric imaging had following region-based performance: sensitivity of 71.9% and 74.8% (p = 0.394) and positive predictive value of 61.3% and 74.8% (p = 0.013), respectively. In side-specific analyses of cancer images, the specificity was 72.6% and 89.5% (p < 0.001) and the negative predictive value was 78.9% and 83.5% (p = 0.364), respectively. False-negative cancer on multiparametric imaging was smaller (p = 0.002) and more dominant with grade group ≤2 (p = 0.028) than true positive foci. In the peripheral zone, false-positive regions on biparametric imaging turned out to be true negative on multiparametric imaging more frequently compared with the transition zone (78.3% vs. 47.2%, p = 0.018). In contrast, T2-weighted plus dynamic contrast-enhanced imaging had lower specificity than T2-weighted imaging (41.1% vs. 51.6%, p = 0.042).

CONCLUSIONS

When using deep learning, multiparametric imaging provides superior performance to biparametric imaging in the specificity and positive predictive value, especially in the peripheral zone. Dynamic contrast-enhanced imaging helps reduce overdiagnosis in multiparametric imaging.

Surgical outcomes of robot-assisted radical cystectomy in octogenarian or older patients: A Japanese nationwide study

OBJECTIVE

To evaluate the surgical outcomes of robot-assisted radical cystectomy (RARC) in octogenarian or older patients based on a Japanese nationwide database.

METHODS

The diagnosis procedure combination database was used to extract the data on radical cystectomy cases. Surgical outcomes of RARC in octogenarian or older patients (older group) were initially compared to those of patients younger than 80 years (younger group). Then, the surgical outcomes of RARC in the older group were compared to those of open radical cystectomy (ORC) and laparoscopic radical cystectomy (LRC) in the same age group.

RESULTS

Between 2018 and 2021, 478 RARC cases in the older group and 2257 RARC cases in the younger group were identified. In the older group, ileal conduit, neobladder, and other urinary diversions were carried out in 352 (73.6%), 22 (4.6%), and 104 (21.8%) patients, respectively. In the older group, when compared with the younger group, the complication rate (24.9%), blood transfusion rate (41.4%), and in-hospital mortality (1.4%) were equivalent, while significantly shorter anesthesia time and longer length of stay were observed in the older group (521.0 ± 140.4 min vs. 595.1 ± 141.71 min, p < 0.01, and 32.9 ± 16.8 days vs. 30.6 ± 17.8 days, p = 0.01, respectively). In the comparison of the surgical outcomes of older patients receiving RARC to those receiving ORC (n = 746) and LRC (n = 375), the RARC group had the lowest complication rate and the shortest length of stay, while the shortest anesthesia time was noted in the ORC group.

CONCLUSION

The feasibility of RARC for octogenarian or older patients was demonstrated by the nationwide database study.

Clinical Practice Guidelines for tuberous sclerosis complex-associated renal angiomyolipoma by the Japanese Urological Association: Summary of the update

New clinical issues have been raised through an interval of 7 years from the previous version (2016). In this study, we update the "Clinical Practice Guidelines for tuberous sclerosis complex-associated renal angiomyolipoma" as a 2023 version under guidance by the Japanese Urological Association. The present guidelines were cooperatively prepared by the Japanese Urological Association and Japanese Society of Tuberous Sclerosis Complex; committee members belonging to one of the two societies or specializing in the treatment of this disease were selected to prepare the guidelines in accordance with the "Guidance for preparing treatment guidelines" published by Minds (2020 version). The "Introduction" consisted of four sections, "Background Questions (BQ)" consisted of four sections, "Clinical Questions (CQ)" consisted of three sections, and "Future Questions (FQ)" consisted of three sections (total: 14 sections). Concerning CQ, an agreement was confirmed through voting by the committee members based on the direction and strength of recommendation, accuracy of evidence, and recommendation comments. The present guidelines were updated based on the current evidence. We hope that the guidelines will provide guiding principles for the treatment of tuberous sclerosis complex-associated renal angiomyolipoma to many urologists, becoming a foundation for subsequent updating.

Prognostic impact of the radiological infiltrative feature of primary renal tumor in metastatic renal cell carcinoma

OBJECTIVES

Recent studies suggest that the radiological infiltrative feature (r-IF) of renal tumors is strongly correlated with poor oncologic outcomes in locally advanced renal cell carcinoma (RCC). This study investigated the prognostic impact of r-IF of primary renal tumors in metastatic RCC (mRCC) in comparison with International Metastatic RCC Database Consortium (IMDC) risk model.

METHODS

We retrospectively analyzed 91 patients with previously untreated mRCC. Dynamic computed tomography of the primary renal tumor was reviewed to assess r-IF, defined as a focally/extensively ill-defined tumor interface with normal renal parenchyma.

RESULTS

The median age was 67 years, and 69 patients (76%) were men. Prior nephrectomy was performed in 47 patients (52%). The median size of the primary renal tumor was 6.7 cm, and 50 patients (55%) presented with cT3-4 stage. Overall, 25 (28%)/52 (57%)/14 (15%) patients were classified into IMDC favorable/intermediate/poor-risk groups, respectively. An image review identified r-IFs in the primary renal tumor in 40 patients (44%). The incidences of r-IFs were 28%/46%/64% in IMDC favorable/intermediate/poor-risk groups, respectively. During a median follow-up of 2.6 years, 31 patients (34%) died of RCC. On multivariable analysis, r-IF and IMDC intermediate-poor risks were independently associated with poor cancer-specific survival (CSS). Two-year CSS were 64%/87% in patients with/without r-IF, respectively. C-index was improved from 0.73 to 0.81 by adding r-IF to the IMDC risk factors.

CONCLUSIONS

R-IF of the primary renal tumor was an independent risk factor for poor CSS in patients with mRCC, which may improve the prognostic accuracy when combined with the IMDC risk model.

Measurements of neutrino oscillation parameters from the T2K experiment using 3.6×1021 protons on target

The T2K experiment presents new measurements of neutrino oscillation parameters using 19.7 ( 16.3 ) × 10 20 protons on target (POT) in (anti-)neutrino mode at the far detector (FD). Compared to the previous analysis, an additional 4.7 × 10 20 POT neutrino data was collected at the FD. Significant improvements were made to the analysis methodology, with the near-detector analysis introducing new selections and using more than double the data. Additionally, this is the first T2K oscillation analysis to use NA61/SHINE data on a replica of the T2K target to tune the neutrino flux model, and the neutrino interaction model was improved to include new nuclear effects and calculations. Frequentist and Bayesian analyses are presented, including results on sin 2 θ 13 and the impact of priors on the δ CP measurement. Both analyses prefer the normal mass ordering and upper octant of sin 2 θ 23 with a nearly maximally CP-violating phase. Assuming the normal ordering and using the constraint on sin 2 θ 13 from reactors, sin 2 θ 23 = 0 . 561 - 0.032 + 0.021 using Feldman-Cousins corrected intervals, and Δ m 32 2 = 2 . 494 - 0.058 + 0.041 × 10 - 3 eV 2 using constant Δ χ 2 intervals. The CP-violating phase is constrained to δ CP = - 1 . 97 - 0.70 + 0.97 using Feldman-Cousins corrected intervals, and δ CP = 0 , π is excluded at more than 90% confidence level. A Jarlskog invariant of zero is excluded at more than 2 σ credible level using a flat prior in δ CP , and just below 2 σ using a flat prior in sin δ CP . When the external constraint on sin 2 θ 13 is removed, sin 2 θ 13 = 28 . 0 - 6.5 + 2.8 × 10 - 3 , in agreement with measurements from reactor experiments. These results are consistent with previous T2K analyses.

Novel utility of Vesical Imaging-Reporting and Data System in multimodal treatment for muscle-invasive bladder cancer

OBJECTIVES

To examine the clinical significance of the Vesical Imaging-Reporting and Data System (VI-RADS) in predicting outcome of multimodal treatment (MMT) in muscle-invasive bladder cancer (MIBC) patients.

METHODS

We reviewed 78 pathologically proven MIBC patients who underwent MMT including transurethral resection and chemoradiotherapy, followed by partial or radical cystectomy. Treatment response was assessed through histologic evaluation of cystectomy specimens. Two radiologists categorized the index lesions of pretherapeutic MRI according to the 5-point VI-RADS score. The associations of VI-RADS score with the therapeutic effect of MMT were analyzed. The diagnostic performance of VI-RADS scores with a cut-off VI-RADS scores  ≤ 2 or ≤ 3 for predicting pathologic complete response to MMT (MMT-CR) was evaluated.

RESULTS

MMT-CR was achieved in 2 (100%) of VI-RADS score 1 (n = 2), 16 (84%) of score 2 (n = 19), 12 (86%) of score 3 (n = 14), 7 (64%) of score 4 (n = 11), and 14 (44%) of score 5 (n = 32). VI-RADS score was inversely associated with the incidence of MMT-CR (p = 0.00049). The cut-off VI-RADS score  ≤ 2 and  ≤ 3 could predict the favorable therapeutic outcome of MMT with high specificity (0.89 with 95% confidence interval [CI]: 0.71-0.98 and 0.82 with 95% CI: 0.62-0.94, respectively) and high positive predictive value (0.86 with 95% CI: 0.64-0.97 and 0.86 with 95% CI: 0.70-0.95, respectively).

CONCLUSION

VI-RADS score may serve as an imaging marker in MIBC patients for predicting the therapeutic outcome of MMT.

CLINICAL RELEVANCE STATEMENT

Muscle-invasive bladder cancer patients with a lower Vesical Imaging-Reporting and Data System score can be a good candidate for bladder-sparing treatment incorporating multimodal treatment.

KEY POINTS

• Vesical Imaging-Reporting and Data System (VI-RADS) score was potentially valuable for classifying pathologic tumor response in patients with muscle-invasive bladder cancer. • The likelihood of achieving complete response of multimodal treatment (MMT) decreased with increasing VI-RADS score. • VI-RADS score could serve as an imaging marker that optimizes patient selection for MMT.

Electronic patient-reported outcome (e-PRO) monitoring for adverse event management during cabozantinib treatment in patients with advanced renal cell carcinoma: protocol for a three-arm, randomised, multicentre phase II trial (e-PRO vs paper-PRO or usual care)

INTRODUCTION

Cabozantinib monotherapy is an option for treatment of advanced renal cell carcinoma (RCC). However, cabozantinib dose modification and discontinuation due to symptomatic adverse events (AEs) remains a challenge. The use of patient-reported outcomes (PROs) may help manage symptomatic AEs, which is reported to lead to improved quality of life (QOL), avoidance of drug discontinuation and better survival. This study aims to investigate the clinical benefits of PROs in patients with RCC receiving cabozantinib and the most appropriate medium for PRO monitoring (electronic [e]-PRO or paper-PRO).

METHODS AND ANALYSIS

This study is being conducted at about 35 sites in Japan. Patients aged ≥18 years with unresectable or metastatic RCC initiating treatment with cabozantinib monotherapy are eligible and will be randomised to: (1) e-PRO monitoring, (2) paper-PRO monitoring or (3) usual care without PRO monitoring. Recruitment began in December 2021 (target sample size, 105). Patients start treatment with cabozantinib 60 mg once daily, and in the PRO groups, will record daily medication intake, weight, temperature, blood pressure and AEs. Endpoints include the proportion of patients with a ≥5-point deterioration on the Functional Assessment of Cancer Therapy-Kidney Cancer Symptom Index (FKSI-19; primary endpoint), progression-free survival, QOL, dose adjustments, relative dose intensity, treatment-emergent AEs and frequency of interventions for AEs outside of the scheduled visits. Patient and physician opinions of the PRO monitoring systems and patient compliance with e-PRO/paper-PRO input are also being measured.

ETHICS AND DISSEMINATION

The study is being conducted in compliance with the Declaration of Helsinki, the International Council for Harmonisation guidelines for Good Clinical Practice and the Clinical Trials Act. Written informed consent is being obtained from all patients, and the protocol has been approved by the Hokkaido University Hospital Certified Review Board (approval number, CRB021-005). The results will be presented at conferences and submitted to a peer-reviewed journal.

TRIAL REGISTRATION NUMBER

jRCTs011210055.

A case of repeat oligoprogressive castration-resistant prostate cancer treated with pulmonary metastasectomy

Introduction

Several retrospective studies have demonstrated the efficacy of progressive site-directed therapy for oligoprogressive castration-resistant prostate cancer. However, eligible patients for progressive site-directed therapy in these studies were limited to oligoprogressive castration-resistant prostate cancer with bone or lymph node metastases without visceral metastases, and little is known about the efficacy of progressive site-directed therapy for oligoprogressive castration-resistant prostate cancer with visceral metastases.

Case presentation

We report a case with castration-resistant prostate cancer previously treated with enzalutamide and docetaxel, in which only a solitary lung metastasis was identified throughout the course of treatment. The patient underwent thoracoscopic pulmonary metastasectomy with a diagnosis of repeat oligoprogressive castration-resistant prostate cancer. Only androgen deprivation therapy was continued and his prostate-specific antigen levels remained undetectable for 9 months after surgery.

Conclusion

Our case suggests that progressive site-directed therapy may be effective for carefully selected repeat OP-CRPC with a lung metastasis.

A Phase Ib Study of Durvalumab (MEDI4736) in Combination with Carbon-Ion Radiotherapy and Weekly Cisplatin for Patients with Locally Advanced Cervical Cancer (DECISION Study): The Early Safety and Efficacy Results

We conducted a phase Ib study to examine the safety of a combination of carbon-ion RT (CIRT) with durvalumab (MEDI4736; AstraZeneca) in patients with locally advanced cervical cancer. This was an open-label, single-arm study with a modified 3 + 3 design. Patients with newly diagnosed histologically proven locally advanced cervical cancer were enrolled. All patients received 74.4 Gy of CIRT in 20 fractions and concurrent weekly cisplatin (chemo-CIRT) at a dose of 40 mg/m². Durvalumab was administered (1500 mg/body) at weeks two and six. The primary endpoint was the incidence of adverse events (AEs) and serious AEs (SAEs), including dose-limiting toxicity (DLT). All three enrolled patients completed the treatment without interruption. One patient developed hypothyroidism after treatment and was determined to be an SAE. No other SAEs were observed. The patient recovered after levothyroxine sodium hydrate treatment. None of the AEs, including hypothyroidism, were associated with DLT in the present study. All three patients achieved complete responses within the CIRT region concerning treatment efficacy. This phase 1b trial demonstrates the safety of combining chemo-CIRT and durvalumab for locally advanced cervical cancer in the early phase. Further research is required as only three patients were included in this study.

Utility of an endoscopic image processing system for framing laparoscopic images using surgeon's gaze point and voice commands during laparoscopic percutaneous extraperitoneal closure of inguinal hernia in children

Introduction

In laparoscopic surgery, it is the assistant who manipulates the laparoscope and manages the field of view.

Aim

To develop an endoscopic image processing system that can adjust laparoscopic images as intended by the surgeon without interrupting the surgical procedure.

Material and methods

We developed a touchless user interface that displays a magnified image of the endoscope using information of the surgeon's gaze point acquired by an eye-tracking device and the surgeon's voice commands, and evaluated its usefulness during laparoscopic percutaneous extraperitoneal closure (LPEC) of pediatric inguinal hernia.

Results

LPEC was performed in 15 clinical cases of pediatric inguinal hernia using this system. In all cases, the internal inguinal ring could be ligated by digitally zooming and moving the endoscopic image by eye tracking and voice command while the scope was fixed.

Conclusions

This new touchless user interface with eye tracking shows promise as a support system for laparoscopic surgery.

Preservation of Erectile and Ejaculatory Functions After Tetramodal Bladder-Sparing Therapy Incorporating Consolidative Partial Cystectomy Against Muscle Invasive Bladder Cancer

OBJECTIVE

To cross-sectionally assess erectile and ejaculatory functions after tetramodal bladder-sparing therapy consisting of transurethral resection, chemoradiotherapy, and consolidative partial cystectomy in patients with muscle invasive bladder cancer.

MATERIALS AND METHODS

Among 72 enrolled male patients who underwent tetramodal bladder-sparing therapy from 2006 to 2019, 42 who visited the outpatient clinic from February to October 2020 received questionnaires. Erectile function, ejaculatory function, and quality of life were assessed using the International Index of Erectile Function short form, the Male Sexual Health Questionnaire Ejaculatory Dysfunction short form, and the Functional Assessment of Cancer Therapy.

RESULTS

Among the 42 patients, 9 were excluded because of incomplete responses and 33 were eligible for analyses. The median (range) age at survey and the time from treatment completion to responding to the questionnaires was 70 (50-87) years and 4.2 (0.4-14.0) years, respectively. The median International Index of Erectile Function short form-5 score was 11 (5-25), and 3 (9.1%) and 9 (27.3%) patients had no and mild erectile dysfunction, respectively. The Male Sexual Health Questionnaire Ejaculatory Dysfunction short form results showed that 23 (69.7%) patients responded that they could ejaculate. Patients with higher Male Sexual Health Questionnaire Ejaculatory Dysfunction short form scores had better erectile function and quality of life than those with lower Male Sexual Health Questionnaire Ejaculatory Dysfunction short form scores.

CONCLUSION

Preservation of erectile and ejaculatory functions was demonstrated in muscle invasive bladder cancer patients treated with tetramodal bladder-sparing therapy. In addition to lower urinary tract function, preservation of male sexual function, especially ejaculatory function, in bladder-sparing therapy can be an advantage over radical cystectomy.

Renal function outcome after selective bladder-preserving tetramodality therapy consisting of maximal transurethral resection, induction chemoradiotherapy and consolidative partial cystectomy in comparison with radical cystectomy for patients with muscle-invasive bladder cancer: a two-centre retrospective study

OBJECTIVE

To compare renal function (RF) outcomes after bladder-preserving tetramodal therapy against muscle-invasive bladder cancer (MIBC) to those after radical cystectomy (RC).

METHODS

This study included 95 patients treated with tetramodal therapy consisting of transurethral bladder tumour resection, chemoradiotherapy and partial cystectomy (PC) and 300 patients treated with RC. The annual change in the estimated glomerular filtration rate (eGFR) was compared using the linear mixed model. Renal impairment was defined as a >25% decrease from the pretreatment eGFR, and renal impairment-free survival (RIFS) was calculated. The association between treatment type and renal impairment was assessed.

RESULTS

The number of patients who received neoadjuvant chemotherapy was 8 (8.4%) in the tetramodal therapy group and 75 (25.0%) in the RC group. After the inverse probability of treatment weighting adjustments, the baseline characteristics were balanced between the treatment groups. The mean eGFR before treatment in tetramodal therapy and RC groups was 69.4 and 69.6 mL/min/1.73 m2 and declined with a slope of -0.7 and -1.5 mL/min/1.73 m2/year, respectively. The annual deterioration rate of post-treatment eGFR in the tetramodal therapy group was milder than in the RC group. The 5-year RIFS rate in the tetramodal therapy and the RC groups was 91.2 and 85.2%, respectively. Tetramodal therapy was an independent factor of better RIFS compared with RC.

CONCLUSIONS

RF was better preserved after tetramodal therapy than after radical therapy; however, even after tetramodal therapy, the eGFR decreased, and a non-negligible proportion of patients developed renal impairment.

A phase II randomized trial of metastasis-directed therapy with alpha emitter radium-223 in men with oligometastatic castration-resistant prostate cancer (MEDAL)

BACKGROUND

The significance of metastasis-directed therapy for oligometastatic prostate cancer has been widely discussed, and targeted therapy for progressive sites is a feasible option as a multidisciplinary treatment for castration-resistant prostate cancer (CRPC). When oligometastatic CRPC with only bone metastases progresses after targeted therapy, it tends to progress as multiple bone metastases. The progression of oligometastatic CRPC after targeted therapy may be due in part to the presence of micrometastatic lesions that, though undetected on imaging, were present prior to targeted therapy. Thus the systemic treatment of micrometastases in combination with targeted therapy for progressive sites is expected to enhance the therapeutic effect. Radium-223 dichloride (radium-223) is a radiopharmaceutical that selectively binds to sites of increased bone turnover and inhibits the growth of adjacent tumor cells by emitting alpha rays. Therefore, for oligometastatic CRPC with only bone metastases, radium-223 may enhance the therapeutic effect of radiotherapy for active metastases.

METHODS

This phase II, randomized trial of Metastasis-Directed therapy with ALpha emitter radium-223 in men with oligometastatic CRPC (MEDAL) is designed to assess the utility of radium-223 in combination with metastasis-directed radiotherapy in patients with oligometastatic CRPC confined to bone. In this trial, patients with oligometastatic CRPC with three or fewer bone metastases on whole-body MRI with diffusion-weighted MRI (WB-DWI) will be randomized in a 1:1 ratio to receive radiotherapy for active metastases plus radium-223 or radiotherapy for active metastases alone. The prior use of androgen receptor axis-targeted therapy and prostate-specific antigen doubling time will be used as allocation factors. The primary endpoint will be radiological progression-free survival against progression of bone metastases on WB-DWI.

DISCUSSION

This will be the first randomized trial to evaluate the effect of radium-223 in combination with targeted therapy in oligometastatic CRPC patients. The combination of targeted therapy for macroscopic metastases with radiopharmaceuticals targeting micrometastasis is expected to be a promising new therapeutic strategy for patients with oligometastatic CRPC confined to bone. Trial registration Japan Registry of Clinical Trials (jRCT) (jRCTs031200358); Registered on March 1, 2021, https://jrct.niph.go.jp/latest-detail/jRCTs031200358.

Long-term effects of primary aldosteronism treatment on patients with primary aldosteronism and chronic kidney disease

OBJECTIVE

Primary aldosteronism (PA) is a major cause of secondary hypertension and is associated with chronic renal injury. The glomerular filtration rate (GFR) in PA rapidly decreases after the removal of glomerular hyperfiltration due to aldosterone excess by adrenalectomy (ADX) or mineralocorticoid receptor antagonist (MRA) treatment and is stable in the long term. However, the effects of these treatments on the long-term renal function of PA patients with chronic kidney disease (CKD) is not well understood.

DESIGN AND PATIENTS

In this single-center, retrospective study, acute and chronic changes in the estimated GFR (eGFR) were examined in 107 patients with PA, including 49 patients with post-treatment CKD　defined as eGFR < 60 ml/min/1.73 m² .

RESULTS

The reduction in eGFR observed 1 month after ADX in the CKD group (N = 31) was -20.1 ± 8.2 ml/min/1.73 m² . Multivariate analysis showed that pre-treatment eGFR and plasma aldosterone concentration were independent predictive factors of the acute reduction in eGFR after ADX. The reduction of eGFR observed 1 month after MRA administration in the post-treatment CKD group (N = 18) was -9.2 ± 5.9 ml/min/1.73 m² . Multivariate analysis showed that the duration of hypertension and pre-treatment eGFR were independent predictive factors of the acute reduction in eGFR after ADX administration. In 20 patients with CKD (N = 12 ADX and N = 8 MRA) followed for more than 5 years post-treatment, there was no further significant decline in eGFR over a follow-up period of 7 (6, 8) years nor any difference between the two treatment modalities.

CONCLUSIONS

Our study suggests that treatment of PA in stage 3 CKD is safe and useful in preventing renal injury.

Trends of radical cystectomy and comparisons of surgical outcomes among surgical approaches focusing on robot-assisted radical cystectomy: A Japanese nationwide database study

OBJECTIVE

To clarify the trends in radical cystectomy and to compare surgical outcomes among surgical approaches focusing on robot-assisted radical cystectomy based on a Japanese nationwide database.

METHODS

The Diagnosis Procedure Combination database was used to extract data on radical cystectomy cases. Trends in open radical cystectomy, laparoscopic radical cystectomy, minimum incision endoscopic radical cystectomy, and robot-assisted radical cystectomy between April 2012 and March 2021 were evaluated. Basic characteristics and peri-operative indicators were compared among the four groups. Propensity score matching was applied to assess the differences between open radical cystectomy and robot-assisted radical cystectomy.

RESULTS

During the study period, a decreasing number of open radical cystectomies and an increasing number of minimally invasive radical cystectomies were shown in the total cohort of 28 345 cases. The number of robot-assisted radical cystectomies rapidly increased after government approval in 2018. Minimally invasive radical cystectomies, including robot-assisted radical cystectomies, had a significantly lower complication rate, a shorter length of stay, and a lower blood transfusion rate, but a longer anesthesia time than open radical cystectomies. In the propensity score matching analysis comparing the surgical outcomes of robot-assisted radical cystectomy and open radical cystectomy, similar results were demonstrated, and blood transfusion rates were equivalent.

CONCLUSION

For the past decade, the number of minimally invasive radical cystectomies has steadily increased without compromised surgical outcomes, except for anesthesia time. Robot-assisted radical cystectomies in particular rapidly became widespread in Japan after government approval in 2018 and became a standard surgery within the first 3 years.

Peritoneal closure and the processus vaginalis transection method to prevent inguinal hernia after robot-assisted radical prostatectomy

OBJECTIVES

Postoperative inguinal hernia (IH) is one of the most common complications of radical prostatectomy (RP) including robot-assisted RP (RARP). However, a procedure to prevent IH after RARP has not been established. We investigated the impact of processus vaginalis transection (PVT) and PVT with peritoneal closure on IH after RARP.

METHODS

A retrospective analysis was performed on data from patients who underwent RARP at two tertiary hospitals in Japan, where PVT with subsequent peritoneal closure was introduced after 2014. The incidence of IH for 2 years after RARP was compared among 79 patients without PVT or peritoneal closure, 232 patients with only PVT, and 325 patients with PVT and peritoneal closure. Multivariable Cox proportional hazard models that adjusted for hospital, age, history of abdominal operation, body mass index, operation time, and prostate weight were used.

RESULTS

Postoperative IH was observed in seven (8.9%) patients without PVT or peritoneal closure, 34 (15%) patients with only PVT, and nine (2.8%) patients with PVT and peritoneal closure. Compared with patients without PVT or peritoneal closure, the incidence of IH was not different in patients with only PVT (hazard ratio [HR] 0.89, 95% confidence interval [CI] 0.34, 2.38) and significantly lower in patients with PVT and peritoneal closure (HR 0.22, 95% CI 0.07, 0.70).

CONCLUSION

PVT with peritoneal closure may reduce the risk of postoperative IH after RARP. Future randomized controlled trials are required to confirm these findings.

Predictive factors for recurrence and outcomes in T1a renal cell carcinoma: Analysis of the INMARC (International Marker Consortium for Renal Cancer) database

728

Background: Stage migration in renal cell carcinoma (RCC) has led to an increasing proportion of diagnoses at earlier clinical tumor stage and has rendered the phenomenon of the ‘small renal mass’ as a dominant presenting clinical paradigm. While thought of as being low risk, emerging knowledge about heterogeneity of RCC histologies and consequent impact on prognosis, in addition to awareness of impact of functional decline and demographic drivers on outcomes led us to further explore outcomes and predictive factors in T1a RCC patients treated with surgical resection. Methods: The INMARC database was queried for patients with small renal masses (≤ 4 cm) who underwent surgery via partial or radical nephrectomy and who presented without nodal or distant metastases. Patients were stratified into two groups based on having recurrence (distant or loco-regional) or not. Primary outcome was overall survival (OS). Multivariable analyses (MVA) were performed to analyze clinicopathological variables associated with recurrence and identify predictors of recurrence, cancer-specific mortality (CSM), and all-cause mortality (ACM). Kaplan-Meier analyses (KMA) were performed to compare recurrence-free survival (RFS), cancer-specific survival (CSS), and overall survival (OS) between histology types clear cell, chromophobe, papillary, and “other.” Results: We analyzed 1,878 cT1aN0M0 RCC patients; 101 (5.4%) developed recurrence (median follow up 53.6 months; median time to recurrence 19.3 months); 51.1% developed distant recurrence, 35.6% had loco-regional recurrence, and 13.9% experienced distant and loco-regional recurrence. MVA demonstrated age (HR=1.02, p=0.02), sex (HR=1.71, p=0.045), diabetes (HR=1.94, p=0.006), high/unclassified grade (HR=2.82-4.40, p<0.001-0.007), papillary (HR=0.37, p=0.013) and other (HR=2.51, p=0.019) RCC as predictive factors for recurrence. MVA identified high/unclassified grade (HR=3.17-6.22, p=0.002-0.003) and papillary RCC (HR=0.12, p=0.036) as predictive factors for CSM. MVA for ACM demonstrated age (HR=1.03, p<0.001), non-Caucasian race (HR=0.85, p<0.001), high grade (HR=1.42, p=0.024), recurrence (HR=1.86, p=0.003), and GFR<45 (HR=2.89, p<0.001) to be independent risk factors. KMA comparing Clear Cell, Papillary, Chromophobe and Other RCC revealed significant differences for 5-year CSS (97.8% vs. 99.3% vs. 98.5% vs. 87.0%, p=0.018) and 5-year RFS (92.4% vs. 96.0% vs. 97.8% vs. 81.7%, p<0.001), but not 5-year OS (89.4% vs. 85.2% vs. 93.2% vs. 73.7%, p=0.34). Conclusions: We noted differential outcomes in T1a RCC based on histology and grade for recurrence and CSM, while renal functional decline in addition to pathological factors and recurrence were predictive for ACM. These findings suggest consideration to refine management and post treatment surveillance strategies in T1a RCC.

Proposal for reclassification of upstaged T1 and T2 and pathological T3 RCC based on improved alignment of survival analyses

732

Background: Patients with pathologically upstaged tumors have worse survival outcomes than their non-upstaged matched counterparts. However, we do know that original clinical tumor staging does still predict outcomes. We sought to examine if pathologic upstaging incrementally may more rationally stratify cancer specific survival outcomes. Methods: Multi-institutional (Emory, TMDU, UCSD) retrospective analysis of patients with renal cell carcinoma who underwent partial or radical nephrectomy between 1998-2020. Patients were divided into cT1 upstaged to pT3 (cT1/pT3), cT2 non-upstaged (cT2/pT2), cT2 upstaged to pT3 (cT2/pT3), and cT3 non-upstaged (cT3/pT3). Patients were analyzed for demographics, clinical parameters, and post-surgical outcomes. Primary outcome was cancer specific mortality (CSM). Secondary outcomes were all cause mortality and recurrence free survival. Cox regression was utilized to analyze factors associated with outcomes. Kaplan Meier analysis (KMA) was performed to analyze 5-year cancer specific survival. ROC analysis was utilized to compare predictive value of AJCC 8th edition TNM staging vs proposed staging. Results: 1093 patients were analyzed (283 cT1/pT3, 237 cT2/pT2, 244 cT2/pT3, and 329 cT3/pT3). Median follow-up was 25.9 months. Cox regression demonstrated that cT2/pT3 (HR 2.7, p<0.001 vs. cT1/pT3 [referent]) and cT3/pT3 (HR 2.6, p<0.001 vs. cT1/pT3 [referent]) were significantly associated with worsened cancer specific mortality, while cT1/pT3 (HR 0.4, p<0.001 vs. cT3/pT3 [referent]) and cT2/pT2 (HR 0.4, p<0.001 vs. cT3/pT3 [referent]) were associated with improved cancer specific mortality. Based on this, we proposed to realign cT1/pT3 with cT2/pT2 and cT2/pT3 with cT3/pT3. KMA revealed significant differences in 5-year cancer specific survival (cT1/pT3 82%, cT2/pT2 81%, cT2/pT3 67%, and cT3/pT3 60%, p<0.001). There were significant differences in 5-year overall survival (cT1/pT3 63%, cT2/pT2 67%, cT2/pT3 49%, and cT3/pT3 49%, p<0.001), and 5-year recurrence free survival (cT1/pT3 80%, cT2/pT2 83%, cT2/pT3 70%, and cT3/pT3 59%, p<0.001) on KMA. ROC analysis revealed an AUC of 0.529 for CSM and AUC of 0.502 for ACM using the current AJCC 8th edition TNM staging. ROC analysis revealed an AUC of 0.597 for CSM and AUC of 0.545 for our new proposal. Conclusions: Our analysis suggests that cT1 tumors pathologically upstaged to pT3 behave more similarly to pT2 tumors. Further delineation of pathologically upstaged tumors may more rationally stratify cancer specific survival outcomes to guide patient counseling and clinical decision making.

Impact of age on functional decline following radical nephrectomy: Analysis of the International Marker Consortium for Renal Cancer (INMARC)

664

Background: Radical nephrectomy (RN) is a mainstay of management of localized renal cancer >4 cm. RN is associated with renal functional decline, however impact of age on functional decline is unclear. We investigated impact of age on post RN function, focusing on decline to moderate and severe chronic kidney disease (CKD). Methods: This was a retrospective analysis of patients who underwent RN. Patients were stratified by age (<50, 50-70 and >70 years). Primary outcome was development of denovo CKD-S 3b [estimated glomerular filtration rate (eGFR) <45 mL/min/1.73m2)]. Secondary outcomes included denovo CKD-S 3a (eGFR<60) and denovo CKD-S 4 (eGFR<30). Multivariable logistic regression analysis (MVA) was utilized to identify risk factors for renal functional decline. Linear regression was utilized to identify risk factors for increasing DeGFR. Kaplan-Meier analysis (KMA) was utilized to evaluate functional outcomes for different age groups Results: We analyzed 2436 patients (<50 years, n=513; 50-70 years, n=1344; >70, n=579; median follow-up 31.9 months). On MVA, increasing age was an independent risk factor for CKD-S 3a (HR=3.4-9.4, p<0.001), CKD-S 3b (HR=3.4-7.7, p<0.001), and denovo CKD-S 4 (HR=1.96, p=0.027). On linear-regression analysis, increasing age was significantly correlated with increased delta eGFR (β=-0.212, p<0.001). KMA Comparing <50, 50-70 and >70 demonstrated age-associated declines in 5-year freedom from denovo CKD-S 3a (73.9%; 50-70 53.7%; and >70 37.06%, respectively, p<0.001), denovo CKD-S 3b (92.7%; 71.8%; and 55.5%, p<0.001) and denovo CKD-S 4 (93.7%; 89.8%; and >70 81.2%, p<0.001). Conclusions: Increasing age is a risk factor for progressive and clinically significant renal functional decline after RN. Prioritization for nephron-sparing management may be considered when indicated and oncologically safe and feasible in elderly patients to reduce potential risk of sequelae of functional decline. [Table: see text]

Preoperative c-reactive protein and risk of major complications and mortality outcomes in patients undergoing surgery for renal cell carcinoma

723

Background: C-reactive protein (CRP) has been demonstrated to be an independent predictor of survival outcomes in renal cell carcinoma (RCC). The use of biomarkers to predict post-surgical complications is not well studied. We sought to investigate predictive factors for major complications following surgery for RCC and delineate their impact on mortality outcomes. Methods: We performed a two-center retrospective analysis of patients who underwent partial (PN) and radical nephrectomy (RN) for RCC. Patients who had complications within 30 days after surgery were identified and the complications were scored using the Clavien-Dindo classification system. Patients were grouped based on whether they experienced 30-day major (Clavien ≥3) complications and whether they had elevated preoperative CRP defined as >5mg/L. Primary outcome was non-cancer mortality (NCM), with secondary outcomes being all-cause (ACM) and cancer-specific (CSM) mortality. Multivariable analyses (MVA) were conducted to evaluate predictors for Clavien ≥3 complications, NCM, CSM, and ACM. Kaplan-Meier analyses (KMA) were performed to compare overall survival (OS), noncancer-specific survival (NCS), and cancer-specific survival (CSS) between patients with non-elevated and elevated preoperative CRP and between patients without and with 30-day Clavien ≥3 complications. Results: A total of 2,234 patients were analyzed [116 (5.2%) experienced Clavien ≥3 complications; median follow up 44 months]. MVA revealed that coronary artery disease (OR 2.37, p=0.005), elevated CRP (OR 2.25, p=0.004), PN (OR 2.79, p<0.001), and open surgical approach (OR 1.74, p=0.049) were predictive of Clavien ≥3 complications. Additionally, MVA demonstrated that elevated CRP was an independent predictor of NCM (HR 2.50, p=0.009), CSM (HR 5.51, p<0.001) and ACM (HR 4.04, p<0.001), while presence of 30-day Clavien ≥3 complications was independently associated with worsened NCM (HR 3.05, p=0.042) but not CSM or ACM. KMA comparing non-elevated and elevated preoperative CRP revealed significant differences for 5-year OS (96.0% vs. 66.8%, p<0.001), 5-year CSS (98.2% vs. 75.6%, p<0.001), and 5-year NCS (97.6% vs. 87.7%, p<0.001). KMA comparing patients without and with 30-day Clavien ≥3 complications revealed significant differences for 5-year OS (87.3% vs. 80.7%, p=0.015) and 5-year NCS (95.6% vs. 87.0%, p<0.001), but not 5-year CSS (91.3% vs. 88.9%, p=0.601). Conclusions: In patients undergoing surgical resection for RCC, elevated preoperative CRP was an independent risk factor for development of 30-day Clavien ≥3 complications, while elevated CRP and development of Clavien ≥3 complications were associated with worsened NCM. Our findings suggest an interplay between major complications and NCM in patients who undergo surgery for RCC, with elevated preoperative CRP being a predictor for both.

Cross-sectional study of patients' (pts) and physicians' needs and the financial toxicity of systemic treatment for metastatic renal cell carcinoma (mRCC) in Japan

702

Background: There is an increasing awareness of the importance of pt-centricity in cancer treatments. To achieve pt-centricity in mRCC treatment, it is important to clarify the differences of preferences between pts and physicians in terms of efficacy, safety, quality of life, and healthcare economics. However, these data are currently lacking for Japanese pts with RCC. This study aims to identify any differences in preferences for drug treatments between pts with mRCC and physicians in Japan, as well as assess the financial toxicity of mRCC and its influencing factors among pts. Methods: This cross-sectional observational study collected data via a web survey of pts with mRCC and physicians. The primary endpoint was to identify the differences in drug-treatment preferences between pts and physicians. The secondary endpoints included identification of the side effects that were most distressing to the pts and those that were most difficult to communicate to the physicians, and the reasons for this. We also evaluated the financial toxicity using the “COST” tool as an exploratory endpoint. Fisher's exact test was used in the evaluation of differences between pts and physicians. Background factors for financial toxicity were evaluated using univariate and multivariate regression analyses. Pearson’s correlation was used to assess the correlation between COST score and FACT-G score. Results: 83 Pts and 165 physicians were included in the analysis. For pts, “eliminating all evidence of disease” ( P < 0.001) was the most important drug-treatment outcome, while for physicians, it was “longer survival” ( P < 0.001). The item of most concern about drug treatment was “disturbing daily activities due to the side effect” for both pts and physicians; while pts were more concerned than physicians about “financial burden” ( P < 0.01) and “lack of the knowledge for the treatment” ( P < 0.001). Diarrhea, fatigue, and vomiting were the most distressing side effects for pts; 51% of pts had difficulty in telling their physicians about side effects such as fatigue, anxiety, and depression. The median COST score was 19 (range, 3–36) and multivariate analysis showed that age and private insurance were independent factors in financial toxicity. In addition, the COST score was positively correlated with the FACT-G total score ( r = 0.40, P < 0.001). Conclusions: There is a gap between pts with mRCC and physicians in their preferences and concerns about drug treatment. Japanese pts with mRCC suffer from side effects, some of which are not shared with physicians, and experience adverse financial impacts even under the universal health insurance coverage system available in Japan. This study highlights the importance of communicating well with pts in clinical practice to achieve pt-centricity in systemic treatment for mRCC.

Summary of the clinical practice manual for late-onset hypogonadism

Testosterone plays an important role in maintaining both physical and mental function. Age-related testosterone depletion contributes to the development of angina, arteriosclerosis, obesity, metabolic syndrome, dementia, frailty, and a range of other conditions. A condition involving age-related testosterone depletion and the associated clinical symptoms is defined as late-onset hypogonadism (LOH). LOH is treated by testosterone replacement therapy. Indications for testosterone replacement therapy are determined by evaluating symptoms and signs.

Impact of worsening surgically induced chronic kidney disease (CKD-S) in preoperative CKD-naïve patients on survival in renal cell carcinoma

OBJECTIVES

To evaluate effects of worsening surgically induced chronic kidney disease (CKD-S) on oncological and non-oncological survival outcomes in renal cell carcinoma (RCC).

PATIENTS AND METHODS

We performed a retrospective analysis of patients who underwent partial (PN) or radical nephrectomy (RN) and were free of preoperative CKD (estimated glomerular filtration rate [eGFR] ≥60 mL/min/1.73 m² ). Patients were stratified by CKD stage at last follow-up: no CKD-S (eGFR ≥60 mL/min/1.73 m² ), de novo CKD-S 3a (eGFR 45-59 mL/min/1.73 m² ), CKD-S 3b (eGFR <45 and ≥30 mL/min/1.73 m² ) and CKD-S 4 (eGFR <30 and ≥15 mL/min/1.73 m² ). The primary outcome was all-cause mortality (ACM). Secondary outcomes included non-cancer mortality (NCM), cancer-specific mortality (CSM) and de novo CKD-S Stage 3/4. Multivariable analysis (MVA) was utilised to identify risk factors for outcomes. Kaplan-Meier analysis (KMA) was utilised to evaluate overall (OS), non-cancer (NCS), and cancer-specific survival with respect to CKD-S categories.

RESULTS

We analysed 3239 patients. The mean preoperative and last-follow-up eGFRs were 87.4 and 69.5 mL/min/1.73 m² , respectively. On last follow-up, 57.9% (n = 1876) had no CKD-S, 18.7% (n = 606) had CKD-S 3a, 15.1% (n = 489) had CKD-S 3b and 8.3% (n = 268) had CKD-S 4. On MVA, de novo CKD-S 3b and 4 were independently associated with ACM (hazard ratios [HRs] 1.3-2.1, P = 0.003-0.001) and NCM (HRs 1.5-2.8, P = 0.021-0.001), but not CSM (P = 0.219-0.909); de novo CKD-S 3a was not predictive for any mortality outcomes (P = 0.102-0.81). RN was independently associated with CKD-S 3-4 (HRs 1.78-1.99, P < 0.001-0.035). Comparing no CKD-S, CKD-S 3a, CKD-S 3b and CKD-S 4, KMA demonstrated worsening outcomes with progressive CKD-S stage: 5-year OS 84% vs 78% vs 71% vs 60% (P < 0.001) and 5-year NCS 93% vs 87% vs 83% vs 72% (P < 0.001).

CONCLUSION

Development of CKD-S Stage 3b and 4, but not 3a, was associated with worsened ACM and NCM. The decision to proceed with nephron preservation via PN should be individualised based on oncological risk and risk of functional decline to CKD-S 3b or 4, and not CKD-S 3a.

Patterns of recurrence in genuine and induced oligometastatic castration-resistant prostate cancer treated with progressive site-directed therapy

OBJECTIVES

To describe oncological outcomes after progressive site-directed therapy (PSDT) in genuine and induced oligometasatic (OM)-castration-resistant prostate cancer (CRPC).

METHODS

Thirty-seven patients with OM-CRPC treated with PSDT were retrospectively analyzed, and oncological outcomes and recurrence patterns on whole-body diffusion-weighted MRI (WB-DWI) were evaluated.

RESULTS

Twenty-two (59%) were classified as genuine OM-CRPC and 15 (41%) as induced OM-CRPC. A 50% decline in PSA after PSDT was observed in 21 (95%) genuine OM-CRPCs and 7 (47%) induced OM-CRPCs (p = 0.0005). At a median observation period of 7.3 months, median PSA progression-free survival were 10.9 months in the genuine OM-CRPCs and 4.8 months in the induced OM-CRPCs (p = 0.015). Among the patients who developed PSA progression after PSDT, 11 of 15 in the genuine OM-CRPCs (73%) and 11 of 14 in the induced OM-CRPCs (79%) underwent WB-DWI at PSA progression. The median numbers of newly detected metastases were 2 (range: 1-5) in the genuine OM-CRPCs and 4 (range: 1-40) in the induced OM-CRPCs (p = 0.049). Only one new metastasis appeared in 5 patients from the genuine OM-CRPCs (46%) and 1 from the induced OM-CRPCs (9.1%, p = 0.048). In 7 of 9 patients from the genuine OM-CRPCs (78%) and 7 of 8 patients from the induced OM-CRPCs (88%) who had bone metastases alone, the newly detected metastasis limited to the bone.

CONCLUSIONS

Genuine OM-CRPC had better oncological outcomes after PSDT than induced OM-CRPC, and the number of lesions detected at recurrence was limited. Induced OM-CRPC might be a disseminated condition with micrometastases at OM diagnosis.

Diagnostic Value of the Vesical Imaging-Reporting and Data System in Bladder Urothelial Carcinoma with Variant Histology

The value of the Vesicle Imaging-Reporting and Data System (VI-RADS) in the diagnosis of muscle-invasive bladder cancer (MIBC) for urothelial carcinoma with variant histology (VUC) remains unknown. We retrospectively evaluated 360 consecutive patients with bladder cancer (255 pure urothelial carcinoma [PUC] and 69 VUC) who underwent multiparametric magnetic resonance imaging between 2011 and 2019. VI-RADS scores assigned by four readers were significantly higher for the VUC group than for the PUC group (p < 0.05). In the cohort of 122 pair-matched patients, there was no significant difference in VI-RADS score distribution between the PUC and VUC groups for all readers (p > 0.05). The area under the receiver operating characteristic curve for MIBC diagnosis via overall VI-RADS score was 0.93-0.94 for PUC and 0.89-0.92 for VUC, with no significant difference between the PUC and VUC groups (p = 0.32-0.60). These data suggests that VI-RADS scores achieved high diagnostic performance for detection of muscle invasion in both PUC and VUC. PATIENT SUMMARY: The Vesical Imaging-Reporting and Data System (VI-RADS) is a standardized system for reporting on detection of muscle-invasive bladder cancer via magnetic resonance imaging (MRI) scans. Our study shows that VI-RADS is also highly accurate for diagnosis for different variants of muscle-invasive bladder cancer, with good inter-reader agreement.